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We animals are the most complicated and 
perfectly-designed pieces of machinery 
in the known universe. It is hard to see 
why anyone studies anything else. 
 
-Richard Dawkins- 
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ABSTRACT 
Common materials acquire new properties when manufactured in the 
nanoscale. The same properties that are responsible for the exciting new 
possibilities are also a cause for some concern. The high surface area to 
volume ratio is a feature of engineered nanomaterials (ENM) that causes the 
amount of surface area to dominate their possible effects. In the case of carbon 
nanomaterials and other fibers, also the shape and length of the particle play 
important roles.  The two ENM studied in this thesis, nanosized titanium 
dioxide (TiO2) and carbon nanotubes (CNT), are among the most widely used 
ENM in the world which means that they hold a high potential of occupationa l 
and possible customer exposure.  
 
Inhalation is the most likely exposure route in occupational settings. For this 
reason, inhalation exposure of mice was the main route of administration. The 
study settings were chosen to mimic occupational exposure as far as possible. 
Different immunological parameters were examined in the lungs of the 
exposed mice, such as the influx of different leucocytes, expression of 
cytokine and chemokine messenger molecules and changes in the lung tissue.  
 
The results from TiO2 studies indicated that even a normally inert material 
when nanosized may become inflammogenic. In addition, even small changes 
in the structure, or even a coating, may modify radically the nature of a 
material. Exposure to most nanosized TiO2 caused only modest to no 
inflammation, whereas a silica (SiO2) coated TiO2 triggered an inflammation 
characterized by pulmonary neutrophilia and mRNA expression of neutrophil 
chemoattractant CXCL1 and proinflammatory TNF-α. In tissues and 
bronchoalveolar lavage (BAL), TiO2 was readily engulfed by macrophages. 
In a model of allergic asthma, it was found that exposure to both nanosized 
and larger TiO2 seemed to prevent asthmatic symptoms. This underlines the 
importance of bearing in mind the heterogeneity of the human population 
when assessing the toxicity of ENM. 
  
CNT have raised some serious concerns in the scientific community and the 
media due to their similarity in structure to asbestos. Here, a remarkable new 
type of eosinophilic inflammation was observed in long rigid CNT exposed 
mice after a week of inhalation to these particles. This inflammation was 
characterized by strong eosinophilia, goblet cell hyperplasia, Th2 type 
cytokines and increased airway hyper-responsiveness to methacholine. All of 
the above symptoms have previously been described as symptoms of classical 
asthma. Transcriptomic analyses revealed radical up-regulation of innate 
immunity and cytokine/chemokine pathways. There were also roles found for 
mast cells and alveolar macrophages in orchestrating the inflammation. 
 
Lastly in the only exposure conducted by aspiration, mice were exposed to 
two long CNT (rigid/R and tangled/T) and to crocidolite asbestos. From a few 
hours to 28 days after a single exposure, there was a striking inflammatory 
cascade starting with macrophages and neutrophils, progressing to 
eosinophilic inflammation and eventually terminating as granulomas, goblet 
cell hyperplasia, Charcot-Leyden-like crystals and the mRNA expression of 
IL-1β, TGF-β, TNF-α and IL-13. The most dramatic inflammation was seen 
in the R/CNT group, followed by asbestos with T/CNT being clearly more 
weakly inflammogenic.  
 
In summary, inhalation exposure especially to certain fibrous nanomater ia ls 
seems to cause strong pulmonary inflammation. This may put exposed 
individuals at risk of developing lung diseases. In addition to the material of 
the nanoparticle, two important factors in risk evaluation are the shape of the 
particle and the possible modification made (e.g. coating) to the particle. The 
model of allergic asthma demonstrated that an underlying inflammatory 
condition can greatly affect the inflammatory outcome seen after nanopartic le 
exposure. The results of this thesis help to understand the underlying 
mechanisms in nanoparticle induced pulmonary inflammation.  
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1 INTRODUCTION 
1.1 Engineered nanomaterials and nanotechnology 
At the beginning of this millennium, nanotechnology, the engineering of 
functional systems at the molecular scale, was just about to take off. Around 
that time, the first studies about the safety of engineered nanomaterials (ENM) 
were published and a gradual arousal swept through the science community 
(Ferin et al. 1991, Oberdorster et al. 2005). At first, there was no consensus 
on what exactly would be best to investigate with regard to nanotoxicology. 
In fact, at that time, it was not even clear what should be categorized as an 
ENM. Eventually, as more and more studies emerged, the area of nanosafety 
research became more focused. Even so, still to this day, researchers have not 
succeeded in identifying a single characteristic that could be used as a way of 
assessing the toxicity of a single ENM.  
 
In 2011 the European Commission described a nanomaterial as "a natural, 
incidental or manufactured material containing particles, in an unbound state 
or as an aggregate or as an agglomerate and where, for 50% or more of the 
particles in the number size distribution, one or more external dimensions is 
in the size range 1 nm – 100 nm." (Commission 2011). Nanomaterials, as such, 
are not new and they exist in nature all around us. They can be found in ocean 
spray, fine sand, clay, dust, clouds and volcanic ash. They are also produced 
during human activities e.g. running car engines, burning wood, smoking a 
cigarette, peeling an orange, making paper copies, mining or even while frying 
food. Nanomaterials are also present in biological materials, e.g. as viruses or 
parts of a cell. On the other hand, ENM are materials that have been 
deliberately manufactured, have one dimension not more than 100 nm and 
possess carefully designed characteristics such as size, shape, surface 
properties and possibly attached functional groups. The behavior of ENM 
often depends more on their surface area than on the actual composition of the 
particle. It is this high surface area to volume ratio that makes nanomater ia ls 
so special in enhancing their potency, electrical properties and reactivity 
(Lohse 2013). In a 500 nm particle, only about 5% of its atoms are on the 
surface of the particle, but with a 50 nm particle every second atom is located 
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on the surface. This large proportion of atoms on the surface means that many 
atoms are able to react with their environment. In addition to the special 
properties conferred by their small size, ENM are also more likely to react 
with cells as they are in the same size range as crucial biological compounds, 
e.g. proteins and DNA. In fact, nanomaterials can be considered as a link 
between bulk materials and molecular structures (Dobrovolskaia et al. 2013). 
   
The nanomaterials studied in this thesis, titanium dioxide (TiO2) and carbon 
nanotubes (CNT), were chosen in the light of their extensive use, leading to 
substantial potential for human exposure. These nanomaterials belong to two 
distinctive groups: CNT is categorized as a high-aspect-ratio (HARN) whereas 
TiO2 is grouped into the low-aspect-ratio nanoparticles (LARN). HARN in 
general include tubes and wires whereas LARN tend to be spherical, oval, 
cubic, prism-, helical-, or pillar-shaped ENM. (Editors 2012) In addition to 
direct exposure to humans, ENM may pose dangers to the environment and 
eventually humans if not recycled or otherwise managed appropriately after 
their use. It has proved difficult to assess their effects on wild animals, 
livestock and eco-systems in general. All in all, it is recommended to 
acknowledge the entire life cycle of created materials.  
1.1.1 Titanium dioxide  
Titanium dioxide (TiO2) nanoparticles are widely used in many applications 
and manufactured worldwide in large quantities. TiO2 exhibits no absorption 
in the visible region providing it with a very white color. TiO2 also has a very 
high refractive index, meaning that it scatters light strongly. These properties 
make it the most widely used white pigment. TiO2 is incorporated into paints, 
coatings, plastics, papers, inks, pharmaceuticals, food products, cosmetics 
(especially sunscreens), and toothpaste. In fact, it is in the top five 
nanoparticles used in consumer products. When particles are nanosized, they 
possess different physicochemical properties than larger particles of the same 
composition. This influences their bioactivity and has resulted in a change of 
opinion about nanosized TiO2. Previously TiO2 was considered to be very 
inert, in fact it was commonly used as a negative control in many studies (Shi 
et al. 2013). TiO2 occurs in three crystal structures: anatase, rutile and 
brookite, (figures 1 and 2), of these, rutile is the most stable. Anatase 
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functions as a photocatalyst when excited by UV light, and thus is able to 
hydrolyze water. In addition to these naturally occurring forms, TiO2 also has 
eight other modifications: three metastable phases and five high pressure 
forms (Finnegan et al. 2007, Hashimoto et al. 2005, Winkler 2003). 
      
Figure 1. Rutile (www.jejaringkimia.web.id), anatase (www.museumwales.ac.uk) 
and brookite (www.mindat.org) crystal forms of titanium dioxide. 
                      
Figure 2. Unit cells of (A) rutile, (B) anatase and (C) brookite. Grey and red spheres 
represent oxygen and titanium, respectively. http://reuniz.com/introduction-to-
titanium-dioxide/ 
Many research articles have been published on TiO2 nanoparticles and their 
toxicology (figure 3). Researchers have been able to demonstrate that the 
physicochemical characteristics including size, surface properties, shape and 
the crystal form of nanosized TiO2 particles have different degrees of toxicity 
to different organism groups under different conditions (Zhang et al. 2015). It 
was proposed in a study by (Li et al. 2010), that nanosized (3nm) TiO2 might 
pass through the blood–brain barrier (BBB), and induce brain injury through 
the oxidative stress response. Another study showed that intra-nasally instilled 
nanosized TiO2 could potentially be translocated into the central nervous 
system via the olfactory nerves and there cause potential brain lesions mainly 
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in  the hippocampus (Wang et al. 2008). (Ferin et al. 1992) showed already in 
1992 that migration of particles to the interstitium was related to the particle   
size, the delivered dose, and the delivered dose rate. They also showed that 
nanosized TiO2 (20 nm) access the pulmonary interstitium easier than larger 
finesized TiO2 (250 nm). A more recent study shows that long-term exposure 
to nanosized TiO2 results in its deposition in pulmonary tissue and possibly 
great alveolar cells (pneumonocytes) (Li et al. 2013). Pulmonary exposure to 
TiO2 has been shown to cause at least inflammation, oxidative stress, 
apoptosis, biochemical dysfunction, cytotoxicity and genotoxicity in murine 
lungs. Also ecotoxicity, phototoxicity and phytotoxicity has been observed 
(Sha et al. 2015, Zhang et al. 2015). General remarks are difficult to make 
because of the vast amount of different materials and unfortunate insufficiency 
of characterization in many cases. 
 
In addition to exposure by inhalation TiO2 has vast potential for dermal 
exposure due to its use in cosmetics and sunscreens. (Wu et al. 2009) showed 
in their study that nanosized TiO2 was able to penetrate the skin and to travel 
to different tissues inducing diverse pathological lesions in hairless mice. 
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Figure 3. Number of publications listed in PubMed during the years 2000-2016/03. 
Search words "titanium dioxide, nanoparticles, toxicity" and "carbon nanotubes, 
toxicity" were used on 29.3.2016. 
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However, (Adachi et al. 2013) did not find evidence of skin penetration in the 
hairless rat. A third dermal exposure study demonstrated an increase in ear 
swelling, suggesting that extremely high concentrations of nanosized TiO2 
may cause dermal irritation (Auttachoat et al. 2014). More research in this area 
is urgently needed. 
 
TiO2 exposure has also been studied together with asthma on several 
occasions. (Jonasson et al. 2013) used mice with ovalbumin (OVA)-induced 
airway inflammation to show that exposure to nanosized TiO2 modulates the 
inflammation depending on the inflammatory status of the mice. They 
conclude that exposure to nanosized TiO2 may aggravate respiratory diseases. 
TiO2 nanoparticles were shown to significantly increase the inflammatory 
response in toluene di-isocyanate-sensitized animals in a study by (Hussain et 
al. 2011) while (Larsen et al. 2010) showed that nanosized TiO2 may act as an 
adjuvant. In another study it was shown that exposure to TiO2 nanopartic les 
during a critical window of vulnerability in lung development may lead to a 
higher risk of developing asthma  (Scuri et al. 2010). An interesting study done 
on OVA-sensitized rats showed that allergic pulmonary inflammation is not 
up-regulated by inhalation of nanosized TiO2, but on the contrary decreases 
lung inflammation (Scarino et al. 2012). 
 
All in all, the traditional negative control particles are no longer considered 
valid and the International Agency for Research on Cancer (IARC) has even 
classified TiO2 as a Group 2B carcinogen (possibly carcinogenic to humans)  
(Baan et al. 2006).  
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1.1.2 Carbon nanotubes 
Graphene was first produced in a lab in 2004 and in 2010, the Nobel Prize in 
Physics was awarded “for groundbreaking experiments regarding the two-
dimensional material graphene". Graphene is a one atom thick sheet of pure 
carbon, with atoms bound in a hexagonal lattice structure. It is the basic 
building block for carbon nanotubes (CNT). Graphene can also exist as a 
single layer of graphite. CNT are formed from graphene sheets that are rolled 
into cylindrical tubes (figure 4). CNT have many unique mechanical and 
electrical properties, an unusual thermal conductivity and unique tensile 
strength, which make them attractive materials for a variety of applications. 
For example, CNT are increasingly appearing in new composite materials, 
electronics, heating elements and biomedical applications (e.g. bone grafting, 
dental implants and drug delivery systems). CNT can be divided into single-
walled or multi-walled carbon nanotubes (SWCNT or MWCNT) depending 
on how many layers of graphene they possess. SWCNT usually have an outer 
diameter of 1-3 nm, whereas MWCNT are 10-200 nm in diameter. CNT vary 
from a few hundred nanometers to several tens of micrometers in length. It is 
difficult to evaluate their potential health effects (figure 3) because of the wide 
range of physical and chemical properties that vary depending on the 
production techniques and possible functionalization (De Volder et al. 2013, 
Grosse et al. 2014, Oberdörster et al. 2015, Wang et al. 2013).  
Figure 4. Graphene and 
carbon nanotubes as (A) 
single wall carbon nanotube 
(SWCNT) and (B) multi-
wall carbon nanotube 
(MWCNT) structures. (Vidu 
et al. 2014) 
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The dangers that CNT pose are likely to be a sum of features of both ENM 
and conventional fibers. In general, fibers have been defined by the World 
Health Organization (WHO) in 1997 to have a length greater than 5 μm, a 
width less than 3 μm and a length to width ratio (aspect ratio) greater than 3:1 
((WHO) 1997). When evaluating effects of a CNT, the first property to be 
considered that can influence the toxicity is the length of the fiber, since this 
not only affects the deposition of the CNT but also determines whether or not 
they can be effectively phagocytized and cleared by the macrophages. The 
critical size according to the paradigm for long fibers is longer than 15-20 μm. 
The paradigm (figure 5) also states that the composition does not affect the 
pathogenicity. However features such as reactive surface or the capacity to 
release biologically active ions, may also contribute to the material’s toxicity. 
Long fibers are described as those being significantly larger than macrophages 
(10 μm), thus posing problems for these cells as they try to engulf these fibers. 
Secondly the biopersistence and the solubility of the CTN affects whether or 
not the fibers can be broken down and cleared or dissolved completely or if 
they will remain intact. Biopersistent long fibers result in 
incomplete/frustrated phagocytosis, cell activation and failed clearance, 
leading to inflammation, fibrosis and eventually even to the development of a 
cancer (Boyles et al. 2015, Donaldson et al. 2006, Donaldson et al. 2010, 
Donaldson et al. 2010, Liu et al. 2012, Oberdörster et al. 2015, Osmond-
McLeod et al. 2011).  
THIN 
Small aerodynamic diameter 
enables deposition beyond 
the ciliated airways. 
BIOPERSISTENT 
Fibers keep their original shape in the lungs, causing 
long fibers to accumulate. 
LONG 
Larger than macrophages. Frustrated phagocytosis is caused by the 
inability of macrophages to completely engulf the fibres. This makes 
clearing long fibers out very ineffective. 
Figure 5. Diagram illustrating a pathogenic fiber according to the pathogenicity 
paradigm and the role of particle characteristics. Adapted from (Donaldson et al. 
2010) and www.jamesheberg.com. 
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In general, studies so far show that pulmonary exposure of both mice and rats 
to MWCNT causes inflammation, granulomas and interstitial fibrosis (Aiso et 
al. 2010, Oberdörster et al. 2015, Pauluhn 2010). A study by (Sargent et al. 
2014) e.g. indicated that exposure to MWCNT strongly promotes the 
formation of lung tumors. It has also been shown that MWCNT are able to 
travel to the pleura and diaphragm once deposited in the lungs (Mercer et al. 
2010, Mercer et al. 2013, Ryman-Rasmussen et al. 2009). Evidence also 
points to qualitatively similar results with both inhalation and bolus (e.g. 
aspiration) exposure studies as well as both commonly used rodents, mice and 
rats (Kasai et al. 2015, Mercer et al. 2013). 
 
The authors of a recent paper (Kolosnjaj-Tabi et al. 2015) claimed that humans 
are routinely exposed to anthropogenic CNT. They claimed that CNT are the 
main component of fine particulate matter (PM) in air pollution thus 
contributing to adverse health effects and responsible for deaths all around the 
world. The effects caused by PM2.5 (PM with diameter of less than 2.5μm) 
have been ranked as one of the leading causes of death and disability across 
the world (Lim et al. 2012). The participants in that study were asthmatic 
Parisian children and whether or not their asthma was a cause or an effect of 
the CNT exposure remains to be clarified (Kolosnjaj-Tabi et al. 2015).  
 
Exposure to MWCNT and asthma have been linked in a couple of studies. 
(Ronzani et al. 2013) showed that when mice were exposed to house dust mite 
and MWCNT, the MWCNT dose-dependently increased the systemic immune 
response, airway allergic inflammation and remodeling induced by house dust 
mite exposure alone. In another study by (Mizutani et al. 2012) exposure to 
MWCNT and an antigen (OVA) demonstrated a biphasic increase in airway 
resistance, airway inflammation, goblet cell hyperplasia, and the production 
of antigen-specific antibodies. (Ryman-Rasmussen et al. 2009) studied 
whether inhaled MWCNT would increase airway fibrosis in mice with allergic 
asthma and concluded that individuals with pre-existing allergic inflammation 
may be susceptible to airway fibrosis from inhaled MWCNT. 
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1.2 Occupational safety 
Nanosized TiO2 and CNT are materials to which many workers may come into 
contact. There are some scenarios where occupational exposure levels have 
been assessed e.g. processes where these materials are produced, transported, 
weighted, blended, mixed, inserted into applications or researched (Bello et 
al. 2008, Bello et al. 2010, Cena et al. 2011, Dahm et al. 2012, Erdely et al. 
2013, Han et al. 2008, Johnson et al. 2010, Lee et al. 2010, Maynard et al. 
2004, Methner et al. 2010, Tsai et al. 2009). Occupational exposure is most 
likely to happen during production and handling of the material and in the 
cleaning of the production reactor. In these settings, CNTs usually occur as 
entangled respirable agglomerates. Exposure to CNT during other parts of 
their life cycle is possible, but regarded as being low according to the availab le 
data (Grosse et al. 2014, Kingston et al. 2014, Nowack et al. 2013). 
 
There has been effort expended on the occupational safety front to set safe 
limits for exposure to different nanomaterials. Although this is a far-from-easy 
task, attempts have been made to produce critical values like no-observed-
adverse-effect-levels (NOAEL) and lowest-observed-adverse-effect-leve ls 
(LOAEL), which are widely used in risk assessment and by agencies defining 
safe levels of exposure or use. It is therefore crucial that these levels are 
derived from research-based findings, and this means that experiments need 
to be conducted to gain more information which can then be applied in the 
exposure assessment. A recommended exposure limits (REL) of 1μg/m3 has 
already been set for CNT by the US National Institute for Occupational Safety 
and Health (NIOSH Current Intelligence Bulletin 65, 2013; (Zumwalde et al. 
2013)). Also Pauluhn et al. (Pauluhn 2010) set a limit of 0.05mg/m3 for 
MWCNT (Baytubes) using a NOAEL from a 13-week subchronic inhala t ion 
study on rats. Both levels indicate a low safe exposure limit for CNT. NIOSH 
has also given a REL for ultrafine (including engineered nanoscale) TiO2 
which is 0.3mg/m3. This is 10 times lower than the REL for fine TiO2 
(Dankovic et al. 2011). They also have assessed ultrafine TiO2 as a potential 
occupational carcinogen. The New Energy and Industrial Technology 
Development Organization (NEDO) Project of Japan determined the 
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acceptable exposure concentration of titanium dioxide to be 1.2 mg/m3 
(Morimoto et al. 2010). 
 
In addition to REL, other strategies exist to help protect workers. These 
include worker education and training, good working practices and work 
hygiene, personal protection (protective clothing and respirators) and in some 
cases medical screening and surveillance. It is believed that these kinds of 
combined strategies can help to control and minimize workplace exposures to 
ENM (FIOH 2015). 
1.3 Immunity 
Humans have three layers of protection against environmental pathogens: the 
physical barrier followed by non-specific and specific defenses. The physical 
barrier consists of the epithelial layers that reside underneath skin and mucous 
membranes. Each human being is born with an innate immunity system that 
matures during childhood and mounts non-specific responses to pathogens. 
These responses consist of cytokines, antimicrobial substances, fever and 
phagocytosis and they are aided by many white blood cells, includ ing 
macrophages, neutrophils, mast cells, eosinophils, basophils and natural killer 
cells (Medzhitov  et al. 2000). Recent evidence shows that  innate immunity 
possesses a nonspecific immunological memory mediated through epigenetic 
reprogramming in myeloid cells or NK cells termed “trained immunity” 
(Netea et al. 2016). The adaptive immune system evolves throughout our lives 
and is altered every time a new antigen is encountered. It produces antibodies 
that are targeted towards certain pathogens and therefore generates pathogen-
specific immunity that sometimes lasts for a lifetime (Medzhitov  et al. 2000). 
1.3.1 Pulmonary immunology and inflammation 
Nanomaterials can enter the body through the gastrointestinal (GI) tract (via 
digestion), the skin (via penetration), blood vessels (via intravenous injection) 
or through the lungs (via inhalation) which is most critical exposure route for 
humans (Krug et al. 2011). Because of the critical role of inhalation exposure 
especially in the occupational context, the present research has focused on the 
lungs and their responses to the presented ENM.  
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During respiration, the human lungs, are continuously exposed to a huge load 
of airborne pathogens and particles. As much as 10,000 liters of air pass 
through our largest epithelial surface daily, and therefore the lungs must 
possess robust mechanisms to house an efficient host defense system. As many 
entering pathogens have the potential to cause lethal infection in the fragile 
tissue designed for gas exchange, the body must mount an appropriate and 
well-regulated immune response in order to clear infections rapidly and 
prevent the development of chronic inflammation. Up to 1010 particles a day 
reach the alveolar region and the immune system has to process them without 
causing inappropriately excessive inflammatory responses that could 
potentially alter the function and architecture of the airways (Bals et al. 2004, 
Boyton et al. 2002, Crapo et al. 2000).  
  
The lungs have many lines of defense against the entry of foreign material. 
The first line of defense is located in the upper respiratory tract where most of 
the inhaled particles are removed. In that region, most of the inhaled particles 
are deposited due to turbulent airflow on the mucus that coats the surface of 
the airways. The mucociliary clearance system then acts to move most 
particles to the posterior pharynx, where they are swallowed and then moved 
through the GI tract (Bals et al. 2004, Boyton et al. 2002, Crapo et al. 2000).  
 
Figure 6. Predicted total and regional deposition probabilities of inhaled particles in 
nasopharyngeal (upper airways), tracheobronchial, and alveolar region of the human 
respiratory tract. Adapted and printed with permission from (Koivisto 2013). 
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Figure 6 demonstrates that the larger particles (over 1 μm) are mostly trapped 
in the upper part of the respiratory tract, the smallest (under 10 nm) in the 
tracheobronchial region and particles between 10 and 100 nm penetrate into 
the deepest parts of the lungs, to the alveoli. In the field of occupational safety, 
two size fractions are considered relevant: inhalable (below 10 μm) and 
respirable fractions (below 4.5 μm aerodynamic diameter). The inhalab le 
fraction is considered to be able to enter the body and the respirable fraction 
to be capable of penetrating beyond the ciliated airways (Donaldson et al. 
2006).  
 
Particle deposition onto respiratory tract depends on many factors such as 
aerodynamic diameter, hygroscopic properties, and charge of the particles. 
Particles over 1 micrometer are deposited mainly by impaction and particles 
below 10 nm by diffusion in the upper airways (blue region in figure 6). The 
main deposition mechanisms in the tracheobronchial region are diffus ion, 
impaction and interception whereas in the alveolar region, the predominant 
mechanisms are diffusion and gravitational settling due to air residence time 
(Asgharian et al. 2007). 
 
Particles that manage to escape the mechanical barriers may travel through 
airways and airspaces, the interstitium and the vasculature. In all these 
compartments, they may undergo processing and may be further presented to 
the extensive lymphoid tissue surrounding the lungs.  
1.3.2 Innate immunity in the lung 
The next level of defense after the mechanical barrier is the innate immunity 
system. Many innate responses have evolved to recognize and respond to 
conserved structures in micro-organisms, such as lipopolysaccharide (LPS), 
and these have been conserved through evolution. These pathogen-associated 
molecular patterns (PAMP) as well as danger associated molecular patterns 
(DAMP) are recognized by the pattern recognition receptors (PRR) present on 
many immune cells. DAMP, e.g. heat-shock proteins, are released in cases of 
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tissue injury and they also participate in the clearance of damaged or apoptotic 
host cells (Medzhitov  et al. 2000).  
Particles that enter the airway surface fluid first encounter a range of soluble 
mediators. The lavage fluid and sputum contain substantial amounts of 
lysozyme; this enzyme acts as an important part of the antimicrobial defense 
and it is made by surface epithelial cells, macrophages and glandular serous 
cells. Lactoferrin is another mediator present in the airway; it is a component 
that kills and agglutinates bacteria and is produced by serous cells and 
neutrophils. Other important components include the α- and β-defensins, the 
collectins and immunoglobulin A (IgA). Human α-defensins or human 
neutrophil peptides (HNP) are present in abundance within neutrophils whilst 
β-defensins are located within the tracheal epithelia. They are both peptides 
with broad antibiotic activity against bacteria, fungi, mycobacteria and 
enveloped viruses and therefore their function is to eliminate or prevent the 
colonization of pathogenic organisms (Fang et al. 2003). The collectins are 
humoral molecules that recognize PAMPs present in plasma and on mucosal 
surfaces. They can implement effector mechanisms like direct opsonizat ion, 
neutralization, agglutination, complement activation and phagocytosis to 
restrain microbial growth. They can also modulate inflammatory and allergic 
responses and apoptotic cell clearance. In all, the collectins limit infection and 
as a result, they attempt to modulate the adaptive immune responses (Gupta et 
al. 2007). IgA is the major class of antibody present in the mucosal secretions  
and it mediates a variety of protective functions via its interaction with specific 
receptors and immune mediators  (Woof et al. 2006). A direct, rapid and 
autonomous response that can be made by epithelia l cells and macrophages is 
the release of type I interferons (IFNs) which leads to a release of factors that 
can interfere with viral replication (Bals et al. 2004, Boyton et al. 2002, Crapo 
et al. 2000).  
 
The lungs contain many immune cells with a variety of functions that deal 
with those particles that succeed in passing through its outer layers. There is a 
substantial population of dendritic cells (DCs) in the lungs that have an 
important role in defense, especially as antigen-presenting cells (APC). 
Furthermore, in some cases, macrophages and B cells can act as APC. 
Alveolar macrophages are however usually recognized as poor APC and it has 
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been postulated that they more commonly function to inhibit further 
amplification of immune pathways and quietly clear away any antigens that 
they come across. When macrophages encounter intruding foreign matter, 
their first response is to attempt to phagocytize the material. Alveolar 
macrophages have an important role in maintaining airway immune 
homeostasis, host defense and tissue remodeling. They are very flexible cells 
and can be specifically modified to fit the special needs of the lungs at any 
given time; this property is dependent on both the macrophages’ state of 
differentiation and the status of the micro-environment. Alveolar macrophages 
communicate with other cells and molecules via specific surface receptors and 
by releasing many secretory products. They also exhibit many PRRs used to 
recognize PAMPs and are involved in the phagocytosis of apoptotic and 
necrotic cells. Macrophages also express a multi-protein complex called the 
inflammasome, which controls the activation and maturation of interleukin-1β 
(IL-1β), a major pro-inflammatory cytokine (Hussell et al. 2014). Interstit ia l 
macrophages (IMs) are macrophages that reside inside the lung tissue. This 
cell type and its function have remained somewhat unknown and not yet fully 
characterized. (Bedoret et al. 2009) stated that IMs have a major role in 
maintaining immune homeostasis in the respiratory tract. The IMs were able 
to inhibit lung DC maturation and migration upon OVA + LPS stimulat ion. 
This is vital in preventing sensitization to inhaled antigens. The lung DCs may 
be paralyzed by the IL-10 produced by IMs, therefore allowing harmless 
antigens to pass without T cell–dependent responses. 
 
Sometimes when the infectious, irritant or antigenic burden becomes too 
massive for the resident cells to handle, they call for help by releasing 
mediators that attract inflammatory cells to the site of attack. Neutrophils are 
recognized as major players in acute inflammation and they are usually the 
first cells to be recruited to the infected or damaged site. Neutrophils are 
continuously generated in the bone marrow from myeloid precursors in a 
process that is controlled by granulocyte colony stimulating factor (G-CSF). 
In times of inflammation, there is an increase in the number of neutrophils in 
tissues. Neutrophils usually live only for some hours, but when activated, they 
can endure for some days. Under normal conditions, these cells can be found 
in the bone marrow, spleen, liver and especially in the lungs. There is some 
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evidence (Kolaczkowska et al. 2013) that there are distinct neutrophil subsets 
with distinct functions, but this theory needs to be confirmed. Neutrophils 
migrate to the lungs from the vasculature following a chemokine gradient 
along the endothelium. These chemokines and the increase in the permeability 
of local blood vessels are attributable to the actions of resident macrophages 
and mast cells. When neutrophils have been activated, they become extremely 
effective in phagocytizing and neutralizing bacteria. They have distinct killing 
mechanisms and can act both intra- and extracellularly. Phagocytized 
pathogens are eliminated inside phagosomes by the many antibacter ia l 
proteins released from granules. Neutrophils can also release these proteins as 
well as antimicrobial histones and proteases into the extracellular milieu to 
target extracellular pathogens. Another extracellular mechanism immobilizes 
pathogens using neutrophil extracellular traps (NETs). Activated neutrophils 
can also further release many other factors such as IL-6, IL-17, TNF-α, IFN-
γ, defensins and IL-1β. Most neutrophils die in the infected tissue while 
performing their function and are cleared away by macrophages. In addition 
to these pro-inflammatory tasks, the neutrophils have been shown to possess 
anti-inflammatory and healing roles and also participate in adaptive immunity 
(promoting humoral and suppressing cellular response) (Kolaczkowska et al. 
2013). 
 
Eosinophils develop in the bone marrow from haematopoietic stem cells and 
their natural role is to defend the body against parasites. Eosinophils contain 
granules which contain enzymes that are released during infections, allergic 
reactions, and asthma. They normally represent less than 5% of leucocytes in 
the blood, but if their numbers should suddenly increase, this can be a 
symptom of many disorders such as allergies, asthma, atopic dermatit is, 
metabolic disorders and the hypereosinophilic syndrome. Recently, roles in 
malignancy and in regulating antibody production as well as participating in 
tumor formation have been proposed. When activated, eosinophils are 
recruited from the blood into the tissues where they act by releasing several 
different products that can also be toxic to airway epithelial cells and may 
contribute to tissue damage, organ dysfunction and tissue remodeling or result 
in a diverse biological activity of eosinophils in infection and inflammation. 
In asthma, the eosinophils are involved in airway hyper-reactivity, elevated 
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mucus production, airway remodeling and asthma exacerbations (Fulkerson et 
al. 2013, Gleich 2000). 
There is one final line of defense in the innate response; the natural killer (NK) 
cells. These cells scout through the body searching out cells with altered 
expression of human leucocyte antigen (HLA) class I tissue antigens. This 
altered expression is caused either by viral infection or transformation and if 
detected by NK-cells, it leads to their activation and to the lysis of the infected 
cells and also the release of interferon-gamma (IFN-γ). IFN-γ in turn may 
recruit other cells to this site. 
 
The mast cells are nowadays considered a link between the innate and adaptive 
immunity. They were first described by Ehrlich (Ehrlich 1956) already in 1878 
and have been considered major players especially in the early and acute 
stages of allergic reactions. Mast cells are derived from haematopoie t ic 
progenitor cells and they circulate in the blood in an immature form. They are 
distributed widely in the body, but are found particularly in the skin, 
respiratory mucosa and the GI track. After migrating to the vascular ized 
tissues, the mast cells undergo final differentiation and maturation assisted by 
the stem-cell factor and other cytokines secreted by endothelial cells and 
fibroblasts. When activated, the mast cells undergo rapid degranula t ion 
releasing a variety of potent inflammatory mediators present within their 
cytoplasmic granules: histamine, proteases tryptase and chymase, chemotactic 
factors, cytokines (such as pre-formed TNF-α) and metabolites of arachidonic 
acid. These mediators then act on the vasculature, smooth muscle, connective 
tissue, mucous glands and inflammatory cells. Some hours after activation, the 
transcriptional up-regulation of cytokines and chemokines, including TNF-α 
and interleukin-4, can be observed. In all, the mast cells are capable of elicit ing 
a wide array of responses that may occur alone or in combination depending 
on the stimulus.  
 
The mast cells also play a central role in the initiation of the allergic reaction 
as they sometimes respond in an inappropriate manner to innocuous antigens.  
They act as the main effector cell responsible for IgE-mediated allergic 
reactions. Mast cells are also capable of processing and presenting antigens 
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through MHCI and MHCII complexes, thus playing an important role in 
sensitization. Furthermore, they provide signals that induce IgE synthesis by 
B-lymphocytes and also induce Th2 lymphocyte differentiation. Because of 
their crucial location, their evident plasticity, and the various mediators they 
are able to produce, the mast cells prove to be important immune effector and 
modulatory cells that bridge the innate and adaptive immunity (Amin 2012, 
da Silva et al. 2014, Urb et al. 2012).  
1.3.3 Adaptive immunity in the lung 
If the innate immune defenses are unable to terminate an attack, the adaptive 
immune system is activated. The adaptive response can be mediated by the 
antibodies that are produced by B lymphocytes. In this case, the response is 
often called humoral. In the cell-mediated immunity, the main players are 
called T lymphocytes. The B cells use antibodies to attack invading bacteria, 
viruses, and toxins. The T cells on the other hand target the body’s own cells 
that have themselves been infected by viruses or become cancerous. 
 
Just as in other tissues of the body, the adaptive immune response starts with 
immature DCs at the site of inflammation ingesting the pathogen and 
travelling to the regional lymph nodes (LN). While they travel to the LN, the 
DC mature and start expressing co-stimulatory molecules in addition to 
breaking down the pathogen and displaying its pathogen peptide fragments on 
their surface. Exogenous antigens are broken down and presented in the MHC 
class II complexes while the endogenous antigens, self- or viral proteins, are 
cleaved by proteasomes and turned into MHC class I peptide complexes 
(Lesterhuis et al. 2004). When DC reach the LN, they encounter naïve T cells 
that possess T cell receptors (TCR) that are able to recognize specific 
antigenic pathogen peptides. When the mature DC encounters a naïve T cell 
that recognizes and binds the specific antigenic peptide, the T cell becomes 
activated not only via the signal of the antigen recognition but also by the co-
stimulatory molecules expressed on the mature DC. Once the naïve T cell is 
activated, it differentiates into an effector T cell and makes multiple copies of 
itself.   
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Effector T cells are classically divided into three classes: CD8 cytotoxic 
(killer, Tc) T cells, CD4 T helper 1 (Th1) cells and CD4 T helper 2 (Th2) cells. 
Tc cells kill target cells, often infected by intracellular pathogens such as 
viruses, that display antigens bound to major histocompatibility complex 
(MHC) class I molecules on the cell surface. Th cells, which both express the 
CD4 co-receptor, respond to antigens displayed on MHC class II molecules. 
Recently, also other lineages of Th cells have been described: e.g. Th17, 
regulatory T cells (Treg), Th22, Th9 and follicular helper T cells (Tfh). 
1.3.3.1 Th1 vs Th2 
The oldest known classes of Th cells, types 1 and 2 respectively, represent two 
very distinctive aspects of the adaptive immunity. Whether T cells develop 
into Th1 or Th2 can depend on many factors that influence the polarization e.g. 
the route of antigen entry, type of the APC, cytokine microenvironment and 
the expression of co-stimulatory molecules. Th1 cells are produced in response 
to intracellular pathogens, apoptosis of tissue cells and autoimmune diseases. 
Th2 cells, on the other hand, respond to extracellular parasites and allergic 
inflammation. IL-12, IFN and transcription factor T-bet have been associated 
with the Th1 inducing pathway, whereas IL-4 and transcription factor GATA3 
have been linked to the Th2. Once activated, Th1 cells produce many different 
bioactive compounds, e.g. IFN-γ, IL-2 and TNF whereas Th2 cells synthes ize 
IL-4, IL-5, IL-6, IL-9, IL-10 and IL-13.  Th2 cytokines are able to induce all 
of the hallmarks of allergic inflammation and asthma: IgE antibody production 
in B-cells, airway remodeling, mast cell growth, eosinophil accumulat ion, 
mucus hyper-production and airway hyper-responsiveness (Romagnani 2000). 
Th1 cells are specialized in activating macrophages, whereas Th2 cells mainly 
target B cells. (figure 7) Th1 and Th2 cells compete by inhibiting the 
differentiation of naïve CD4 T cells into each other, i.e. Th2 produced 
cytokines inhibit Th1 differentiation and vice versa (Boyton et al. 2002, 
O’Garra 2000, Rincón et al. 1997).  
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Figure 7. Different factors in Th1 and Th2 differentiation, the cytokines 
produced and the target cells. 
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1.3.4 Cytokines  
Different immune cells communicate with other cells by releasing small 
proteins called cytokines. The responding cells have specific receptors on their 
surfaces to which the cytokines bind. Cytokines are a very diverse group of 
biomolecules that is able to provoke a variety of responses in sensitive cells.  
Cytokines act to ensure that there is coordination of the appropriate immune 
responses. For example as described before, the subtypes of T cells are 
partially determined by the cytokine microenvironment in which they are 
maturing and the cytokines they produce upon activation are used to describe 
the different T cell subtypes.  
 
Interleukins are a group of cytokines first found to be secreted by leucocytes 
to communicate with other leucocytes. Later they were found to be expressed 
by several other cells as well. IL-1β belongs to the IL-1 family and is a potent 
pro-inflammatory cytokine that acts as an endogenous pyrogen. IL-1β is one 
of the most important cytokines involved in the initiation and persistence of 
inflammation and for this reason, its induction is stringently controlled. IL-1 
is produced mainly by macrophages and monocytes, but also by bronchial and 
alveolar epithelial cells, neutrophils, T-cells and fibroblasts. The pro-IL-1β is 
a precursor of the active form of IL-1β and it lacks biological activity. Auto-
activated caspase-1 enzyme (ICE) or alternatively proteases cleave pro-IL-β 
into its active form (Dinarello 1996, Lappalainen et al. 2005, Martinon et al. 
2002). The effects on the immune functions of IL-1 family members are 
indirect, but they are able to provoke fever, reduced pain threshold, 
vasodilatation and hypotension. IL-1β can increase the expression of adhesion 
molecules and induce chemokines. It is also an angiogenic factor and in this 
respect, it plays a role in tumor metastasis and blood vessel formation 
(Dinarello 2009). IL-33 also belongs to the IL-1 family; it is a strong inducer 
of Th2 responses. IL-4, IL-5 and IL-13 are considered Th2 type cytokines that 
are usually expressed during IgE-mediated allergy. They are known to mediate 
IgE production, eosinophilia and immunity against helminth infection. IL-4 
belongs to the γ-chain family, regulates allergic conditions and is a major 
stimulus of Th2-cell development. IL-5 is a strong promoter of eosinophil ia 
and an inducer of hyper-reactivity in asthmatic patients. IL-13, on the other 
hand, has been linked to fibrosis, induction of IgE production, regulation of 
INTRODUCTION 
21 
NF-kB activation and related cytokine/chemokine generation, activation and 
recruitment of mast cells and eosinophils while promoting their survival as 
well as some anti-inflammatory properties. IL-10 is a classical member of the 
family to which it gave its name (the IL-10 family) and acts as an anti-
inflammatory factor regulating the inflammatory response (Akdis et al. 2011, 
Lentsch et al. 1999).  
 
IFN-γ is an important link between the innate and adaptive systems; this 
cytokine is secreted by cell populations belonging to both immunity systems. 
IFN-γ has numerous roles in addition to activating macrophages, for example 
it can interfere with viral infection mainly by inducing antiviral enzymes 
(Akdis et al. 2011). 
 
A member of the TNF superfamily, TNF-α, is first produced in a 
transmembrane form that is expressed by activated macrophages and 
lymphocytes and perhaps by other cells as well. The soluble form is then 
cleaved from the membrane. There is recent evidence suggesting that both 
forms are involved in inflammatory responses. TNF-α has been described as 
one of the most important inflammatory mediators and its activation is a 
crucial component of the innate immune system (Bradley 2008, Hehlgans et 
al. 2005). 
 
Transforming growth factor-β (TGF-β) is considered to be anti-inflammatory, 
but it has a strong pleiotropic role - its effects can be different, or even 
opposite, depending on the cell type and the conditions. It has an important 
role in establishing immunological tolerance, but also has pro-inflammatory 
roles. For example, normally TGF-β induces Foxp3-positive regulatory T cells 
(iTregs), but when IL-6 is present, it induces the creation of the pathogenic IL-
17 producing Th17 cells (Massague 2012). 
 
Chemokines are a specific group of cytokines that chemically attract more 
immune cells to the site of inflammation to help combat invaders or repair 
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tissue damage. Many of these agents have additional homeostatic or 
housekeeping functions. Chemokines possess three to four conserved cysteine 
residues and are subdivided into 4 families based on the position of the N-
terminal cysteine residues. The C-X-C-family and C-C family can also be 
distinguished by their primary target cell, with the C-X-C subfamily targeting 
neutrophils and the C-C family targeting eosinophils, monocytes, and T cells 
(Commins et al. 2010). The specific chemokines examined in this thesis are 
listed below in table 1. 
Table 1. Chemokines appearing in this thesis listed with their physiologic features 
and functions. Adapted from (Commins et al. 2010). 
CC 
chemokine/receptor 
family 
Physiologic 
features Functions 
CCL2 inflammation 
contributes to AHR and cellular emigration in 
asthma, promotes TH2 phenotype, role in 
wound healing 
CCL3 inflammation, 
homeostasis 
promotes development of IFN-γ TH1 cells, 
role in asthma 
CCL7 inflammation promotes TH2 phenotype, role in asthma 
CCL11 inflammation, 
homeostasis 
contributes to AHR and cellular emigration in 
asthma, most important eosinophil 
chemoattractant in allergic inflammation 
CCL17 
inflammation, 
homeostasis 
promotes TH2 phenotype 
CCL24 inflammation role in asthma 
   
CXC 
chemokine/receptor 
family 
  
CXCL1 
inflammation, 
homeostasis 
angiogenic, neutrophil chemoattractant  
CXCL2 inflammation 
angiogenic, chemotactic for 
polymorphonuclear leukocytes  and 
hematopoietic stem cells  
CXCL5 inflammation angiogenic, neutrophil chemoattractant 
CXCL8 inflammation 
role in wound healing, asthma and allergic 
diseases, one of the most potent neutrophil 
chemoattractants 
CXCL9 inflammation T-cell chemoattractant, induced by IFN-γ 
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1.3.5 Transcription factors  
Transcription factors are proteins that bind to specific DNA sequences. When 
binding to DNA, they either increase or decrease gene transcription.  FOXP3 
(forkhead box P3), a member of the forkhead transcription factor family, is 
mainly expressed in a subset of CD4+ T-cells that act as suppressors in the 
immune system. FOXP3 also functions as a transcription activator for many 
genes. It is known that FOXP3 plays a crucial role in the development and 
function of regulatory T cells and is used as a marker for regulatory T cells  
(Kim 2009). 
1.4 Asthma  
Asthma and allergies have become everyday acquaintances of the citizens in 
the industrialized countries, where these disorders are distressingly common. 
It has been estimated that 300 million people worldwide suffer from asthma 
and 250,000 people die annually because of the disease. About 70% of 
asthmatics also have allergies (WHO 2007). The development of asthma in an 
individual is a product of a genetic predisposition and environmenta l 
conditions. Children in wealthy countries are more likely to develop allergy-
related asthma than children in poorer nations (Weinmayr et al. 2007). The 
reasons for increasing asthma occurrence are still to be established, but they 
have been linked to improved hygiene, antibiotics, changes in the diet, 
vaccinations and increased exposure to novel chemicals and environmenta l 
particulate matter (Holtzman 2012, Pandya et al. 2002, Rook 2012, Silverman 
et al. 2010, Stieb et al. 2009).  
 
Asthma is a multifaceted chronic inflammatory disorder of the airways that 
causes pulmonary obstruction. Symptoms, such as mucus production and 
airway hyper-reactivity (AHR), that vary extensively between individuals can 
be triggered by exposure to allergens or irritants such as chemicals (e.g. 
tobacco smoke) or by exercise or infection (Lloyd et al. 2010, William W. 
Busse et al. 2007). The complexity of asthma has recently become more 
evident and it seems that rather than a single disease, asthma is a combination 
of different disease processes with variable etiologies and pathophysiologies. 
Allergic asthma is considered to be a so-called endotype of asthma that is 
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characterized by airway exposure to an allergen that triggers a hypersensitivity 
response in a sensitized individual involving an influx of T lymphocytes and 
eosinophils into the lungs (Afshar et al. 2008, Lötvall et al. 2011). There are 
many immune and inflammatory cells involved in asthma (Barnes 2008), 
which are presented in more detail in figure 8. 
 
 
 
Inhaled allergens 
Mast cell 
Epithelial cells 
IL-5 
CCL11 
IL-4 
Dendritic 
cell 
Th2 cell 
Eosinophilic inflammation 
TSLP 
Treg cell? 
B cell 
IL-9 
Smooth-muscle cells 
CCL17 and 
CCL22 
SCF 
IgE 
IL-13 Bronchoconstriction 
Antibody production 
Histamine, cysteinyl  
leukotrienes and  
prostaglandin D2 
Figure 8. Immune and inflammatory cells involved in asthma. 
Epithelial cells release stem cell factor (SCF), which keeps mucosal mast cells at the airway  
surface. These cells also release thymic stromal lymphopoietin (TSLP) together with mast 
cells to condition myeloid dendritic cells and in addition , secrete the eosinophil 
chemoattractant CCL11. Allergens  are processed by dendritic cells, which react by secreting 
CCL17 and CCL22, which in turn attract T helper 2 (Th2) cells. Allergens also activate 
sensitized mast cells through surface bound IgE molecules. Mast cells react by releasing 
cysteinyl leukotrienes and prostaglandin D2 that in turn act to evoke bronchoconstriction. Th2 
cells act as central mediators of the inflammatory response by releasing interleukin -4 (IL-4), 
IL-13, IL-5 and IL-9. IL-4 and IL-13 stimulate B cells to produce IgE, IL-5 stimulates 
eosinophilic inflammation and IL-9 stimulates mast-cell proliferation. Regulatory T (TReg) 
cells are known to malfunction in asthmatic patients, which may help Th2 cells to proliferate. 
Adapted from (Barnes 2008). 
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In 1985 (Brooks et al. 1985) Brooks et al. proposed a new type of occupationa l 
asthma called Reactive Airways Dysfunction Syndrome or RADS. This 
asthma-like syndrome develops quickly, within hours, after a single exposure 
to high levels of irritating fume, smoke, vapor or aerosol. RADS differs from 
traditional asthma in particular due to its acute nature with no latency period. 
The initial respiratory symptoms are followed by asthma-like symptoms and 
airway hyper-responsiveness. Irritant- induced asthma (IrIA) is another more 
recent term used to describe an asthmatic syndrome that results from a single 
or multiple high dose exposures to irritant products. There is little informatio n 
available on these conditions, but they have been claimed to include 
significant upper airway symptoms, nonspecific inflammation, neurogenic 
inflammation, primarily lymphocytic cellular infiltrate, macrophage 
activation, mast cell degranulation and epithelial desquamation (Brooks 2013, 
Shakeri et al. 2008, Tarlo 2013, Varney et al. 2011).  
1.4.1 The mouse model of asthma 
Allergic asthma is mostly studied using mouse models, because ethical 
reasons forbid carrying out mechanistic studies on asthmatic individuals. Due 
to the very complex nature of allergic asthma, the models cannot give answers 
to all crucial questions, but they can be used to model specific features of the 
disease. In this thesis we used an asthma model to study reactions to ENM 
exposure in mice owing an already burdened immunological status. A variety 
of different models and protocols have been employed in the studies of allergic 
asthma and naturally the findings and conclusions may be influenced by the 
choice of mouse strain, the allergen, as well as the type of sensitization and 
challenge protocol. 
  
The basic and commonly used model (Bates et al. 2009), that was also used in 
this thesis, begins with protein sensitization (usually with ovalbumin) which 
is followed by an airway challenge. Sensitized mice are typically injected 
intraperitonally twice with a combination of the protein and an adjuvant (e.g. 
alum). The injections are given one to two weeks apart. Approximately one 
week after the last injection, the mice are challenged three days in a row to the 
allergen by inhalation or alternatively by intranasal or intratrachea l 
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administration. The inflammatory parameters are measured two days after the 
last challenge. This model reproduces many key elements of clinical asthma, 
e.g. elevated levels of IgE, airway inflammation, goblet cell hyperplas ia, 
epithelial hypertrophy, high concentrations of Th2 type cytokines and 
chemokines as well as AHR and eosinophilia (Nials et al. 2008).  
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2 AIMS OF THE STUDY 
When this thesis work was started, the world of nanotoxicology research was 
an uncharted one. As more and more people potentially became in contact with 
ENM in their work places, concerns arose about the safety of these materials. 
From the occupational safety point of view, this thesis aimed to contribute to 
the debate of whether or not ENM would pose a risk to individuals working 
with these materials. In general, it was decided to examine whether, and if so 
how, these nanoparticles could evoke pulmonary inflammation. This thesis 
also tackles asthma from the point of view of a part of the population that 
might be more sensitive to ENM exposure. In addition, in vitro experiments 
were used, whenever they could add value to the research.   
 
The specific aims were:  
1. To investigate the direct effects of repeated nanoparticle exposure on the 
development of lung inflammation in vivo.  
2. To examine how exposure to nanoparticles modulates the development of 
allergic asthma in vivo. 
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3 MATERIALS AND METHODS 
3.1  Materials (I, II, III, IV) 
The materials and their characteristics are listed in table 2. When purchased 
materials are aerosolized, they tend to form agglomerates (Nichols et al. 
2002). This same phenomenon would however also take place in occupationa l 
settings and thus presents no problem to this research. In aerosol 
characterizations done during exposures we could see that the aerosols 
contained agglomerates and primary particles alike. (I, supplementary figure 
2; II, figure 2; IV, figure 7). 
3.1.1 Aerosol and particle characterization for nanoparticle powders  
(I, II) 
In the TiO2 exposures, the aerosol size distributions were measured from 10 
to 1000 nm with a scanning mobility particle sizer consisting of a 63Ni bipolar 
aerosol neutralizer, a Vienna type differential mobility analyzer with a length 
of 28 cm, and a TSI model 3010 condensation particle counter (Wang et al. 
1990). Aerosol aerodynamic size distribution was measured from 15.9 nm to 
10 μm with an electronic low-pressure impactor (Dekati Ltd., Tampere, 
Finland) (Marjamäki et al. 2000). The aerosol mass concentration was 
determined gravimetrically after collection on nitrocellulose filters (Millipore, 
Billerica, MA). The particle concentration inside the particle dispenser 
chamber was also monitored using a personal DataRAM (online mass 
concentration meter, pDR1000AN; Thermo Scientific, Waltham, MA).   
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The size and morphology of the nanopowders were characterized by electron 
microscopy (Zeiss ULTRAplus FEG-SEM, Carl Zeiss NTS GmbH, 
Oberkochen, Germany and JEM 2010 TEM, Jeol Ltd., Tokyo, Japan) and their 
composition by energy dispersive spectroscopy (EDS; Thermo-Noran 
Vantage, Thermo Scientific, Breda, The Netherlands). The crystallinity and 
phase composition of the nanopowders were determined by powder X-ray 
diffraction analysis (Siemens D-500, Siemens AG, Kahrlruhe, Germany) and 
specific surface area of nanopowders was measured by nitrogen adsorption, 
using the Brunauer-Emmett-Teller method (Coulter Omnis-orp 100CX, 
Florida, USA). 
3.1.1.1 In situ synthesized nanoparticles (I) 
The synthesized aerosol particles were collected with a particle collector 
(fabric filter), from which the properties of the particle were characterized. 
The rest of the analyses were performed as described in 3.1.1. In the 
transmission electron microscope (TEM) analysis, a small volume of aerosol 
was drawn through a 200-mesh copper grid coated with lacey carbon film (SPI 
Supplies, West Chester, PA). 
3.1.1.2 Hydroxyl Radical (·OH) Formation Capacity (I, II) 
The hydroxyl radical (·OH) formation capacity was determined using the 
benzoic acid probe, which captures hydroxyl radicals forming the reaction 
product, 4-hydroxybenzoic acid (4-HBA) (Jung et al. 2006). Powder samples 
were suspended in 10mM phosphate-buffered deionized water with 10mM 
benzoic acid to achieve particle concentrations of 2, 5, 10, and 15 mg/ml. The 
vortexed samples were placed on an orbital shaker (IKA Vibrax, IKA Werke 
GmbH & Co. KG, Staufen, Germany, 1000 rpm) in an incubator at 37°C for 
24 or 90 h. After incubation, the suspensions were centrifuged for 30 min at 
4°C (20,000 × g relative centrifugal force) to remove the particles and 250 μl 
was transferred to a glass vial with the addition of 10 μl 5M HCl to ensure 
protonation prior to chromatographic separation and UV detection of 4-HBA.  
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In the analysis, 50 μl of the acidified sample was injected into a 
chromatographic system consisting of a Waters W600 pump and controller, a 
two serially mounted Waters XTerra MS 5 μm C18 (3.9 × 150 mm) columns, 
a Waters 996 PDA detector, and a Waters 717 autosampler (Waters HPLC, 
Milford, MA). The mobile phases consisted of water adjusted to pH 2 with 
HCl (A) and acetonitrile (B) with the following eluant program: 30% B for 1 
min, 30%–80% B in 4 min, and 80% B for 1min. The flow rate was 1 ml/min, 
and the 4-HBA was detected at 280 nm. The ·OH radicals were measured via 
the 4-HBA concentrations were converted to ·OH concentrations based on the 
21.5% 4-HBA yield from the reaction between benzoic acid and ·OH (Bivas-
Benita et al. 2005). The ·OH formation capacity was then calculated from a 
simple linear regression analysis of the ·OH radicals (nanomole ·OH per 
milliliter) as a function of the dose (milligram powder per milliliter). The 
standard deviation (SD) of the slope was determined as the SD between the 
predicted and observed y-value. All slopes were determined based on doublet 
analysis. All chemicals were obtained from Aldrich (St. Louis, MO).  
3.1.1.3 Z-Potential (I) 
The Z-potential of TiO2 was measured at pH 1–6. TiO2 particles were 
dispersed in 0.1M NaCl, and pH was adjusted with HCl. The Z-potential was 
measured with Zetasizer Nano Series particle characterization system 
(Malvern Instruments, Worcestershire, UK, 2005), and the analysis program 
was DTS (dispersion technology software, Malvern Instruments). Each 
dispersion was measured three times. The pH was determined at which Z-
potential was zero.  
3.1.2 Aerosol and particle characterization for fibrous materials  (III) 
In the CNT exposures, the aerosol concentrations were measured with an 
optical particle sizer (OPS, Grimm Dust Monitor 1.109) by applying the 
instrument calibration refractive index and a particle density of 2.6 g/cm3. 
Gravimetric samples were collected onto nitrocellulose filter (Millipore) and 
weighed on an analytical scale (RADWAG XA 110/Y; RADWAG Wagi 
Elektroniczne, Radom, Poland). 
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The morphology of the CNT was characterized by electron microscopy (Zeiss 
ULTRAPlus FEG-SEM, Carl Zeiss NTS GmbH, Oberkochen, Germany; Jeol 
JEM 2010 TEM, Jeol Ltd., Tokyo, Japan) and their composition was analyzed 
in an X-ray energy dispersive spectroscope (EDS ThermoNoran Vantage, 
Thermo Scientific, Breda, The Netherlands) attached to Jeol JEM 2010 TEM. 
Elemental composition data were expressed as the average of three separate 
analyses. 
3.1.3 Assessment of bacterial lipopolysaccharide content (I, III) 
Both nanosized TiO2 samples that were investigated in detail in the present 
study (cnTiO2 and nanoTiO2 rutile/anatase) were tested for endotoxins to 
ensure that the detected inflammatory effects were not a response caused by 
possible endotoxin artifacts in the test materials. The concentrations of 
endotoxins were assayed in the Kuopio unit of the Finnish Institute of 
Occupational Health, which is accredited as a testing laboratory T013 (EN 
ISO/IEC 17025) by the Finnish Accreditation Service. Measurements were 
made using a standard (SFS-EN 1 4031:2003) kinetic chromogenic method 
based on the Limulus amebocyte lysate. 
 
Levels of biologically active endotoxin in MWCNT were measured using a 
kinetic chromogenic Limulus amebocyte lysate assay (Kinetic QCL, Lonza, 
Walkersville, MD, USA) according to the instructions provided by the 
manufacturer. Endotoxin levels of the material samples were always <0.022 
EU/mg. 
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3.2 In vivo exposure methods 
Table 3 summarizes the main features of all the in vivo exposures described 
in details in the following chapters. 
Table 3. Main features of all the in vivo exposures in the experiments of this thesis. 
Publi- 
cation 
Mouse 
strain 
Exposure 
method 
Exposure 
times Doses Sacrificed Other 
I balb/c inhalation 
2h, 
2h on 4 
consecutive 
days, 
2h on 4 
consecutive 
days on 4 
consecutive 
weeks 
10 
mg/m3 
4h and 24h 
after 1 and 4 
days of 
exposure 
and 24h after 
4 weeks of 
exposure 
 
II balb/c inhalation 
2h on 3 days 
a week for 4 
weeks 
10 
mg/m3 
after AHR 
measure- 
ment on day 
28 
OVA 
(asthmatic) 
vs. PBS 
(healthy) 
III 
c57bl/6,  
balb/c, 
KitW-sh 
/HNihrJa
eBsmJ 
inhalation 
4h, 4h on 4 
consecutive 
days 
6.2-8.2 
mg/m3 
for 
rCNT 
and 
17.5-
18.5 
mg/m3 
for 
tCNT 
immediately 
or 24 h after 
single 
exposure, 
24h after 4 
days  
 
IV c57bl/6 aspiration once 
10 or 
40 μg/ 
mouse 
4 and 16h, or 
7, 14 and 28 
days after 
exposure 
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3.2.1 Animals 
All female mice (6-8 weeks old) listed in table 4 (7-8 weeks old) were 
quarantined for one week before the experiments and randomized into groups 
of eight. The mice were housed in groups of four in stainless steel cages 
bedded with aspen chip and were provided with standard mouse chow diet 
(Altromin no. 1314 FORTI, Altromin Spezialfutter GmbH & Co., Germany) 
and tap water ad libitum, when not in the exposure chamber. The environment 
of the animal room was carefully controlled, with a 12-h dark/light cycle, 
temperature of 20-21 °C, and relative humidity of 40-45 %. The experiments 
were performed in agreement with the European Convention for the Protection 
of Vertebrate Animals Used for Experimental and Other Scientific Purposes 
(Strasbourg March 18, 1986, adopted in Finland May 31, 1990). All studies 
were approved by the Animal Experiment Board and the State Provinc ia l 
Office of Southern Finland. 
 
Table 4. The mouse strains used in the experiments of this thesis. (Gueders et al. 
2009, Watanabe et al. 2004) 
Mouse strain C57BL/6 
BALB/c/ 
Sca 
B6.129S7-
Il1r1tm1Imx/J 
KitW-sh/ 
HNihrJaeBsmJ 
Vendor 
Scanbur 
AB, 
Sollentuna
Sweden 
Scanbur 
AB, 
Sollentuna
Sweden 
Jackson 
Laboratory, 
Bar Harbor, 
Maine 
Scanbur AB, 
Sollentuna 
Sweden 
Special 
characte-
ristics 
Th1/Th2 
phenotype 
Th2 
dominant 
phenotype 
IL-1 receptor 
deficient 
mast cell 
deficient 
Publication III, IV I, II, III IV III 
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3.2.2 Inhalation exposure to nanoparticle powders (I, II) 
Inhalation exposure is considered the golden standard when attempting to 
model occupational exposure. Its only negative feature in mice is that there 
can be some contamination of the fur resulting in some additiona l 
gastrointestinal tract exposure due to preening. The nanoparticles were 
delivered into the whole-body inhalation exposure chamber using a solid 
particle dispenser (Palas Rotating Brush Generator, RBG 1000, Karlsruhe, 
Germany). The operating principle of the dispenser is based on feeding of the 
powdered material at a constant rate to the rotating brush, from where the 
powder is blown out by a high-velocity air stream and carried into the 
inhalation chamber supply air inlet. The stream of aerosol from the disperser 
is mixed with air before entering the inhalation chamber due to the turbulence 
in the air duct.  
3.2.3 Inhalation exposure to in situ synthesized TiO2 nanoparticles (I) 
A TiO2 particle generator was attached to a whole-body inhalation exposure 
chamber to facilitate direct exposure to freshly made TiO2 nanoparticles. The 
particle generator is a laminar flow reactor where TiO2 particles were 
produced by thermal decomposition of titanium tetraisopropoxide (TTIP, 
Titan(IV)-Isopropylat 97%) vapor (Miettinen et al. 2009, Okuyama et al. 
1986). Inside the reactor, the overall reaction stoichiometry was Ti(C3H7O)4 
→ TiO2 + 4C3H6 + 2H2O (Kirkbir et al. 1987). The primary TiO2 particles 
were produced by homogenous nucleation, condensation, and coagulat ion 
from the TiO2 vapor. Secondary particles were formed by agglomeration of 
primary particles and condensation of TiO2 vapor on the particle defined the 
quantities of reactor by-product gas levels at different reactor settings. Gas 
levels were at maximum: 38.4 ppm propane (C3H6), 23.2 ppm carbon 
monoxide (CO), 4.1 ppm methane (CH4), 2.1 ppm nitrogen oxides (NOx), and 
additional oxygen and water vapor.  
3.2.4 Inhalation exposure to fibrous materials (III) 
MWCNT were aerosolized with a fluidized bed aerosol generator (FBAG; TSI 
Model 3400A, (Marple et al. 1978)) for which the materials were used without 
any pre-treatment. In the generator, a chain transports CNT to the fluidizing 
bed where any material agglomerates are mechanically broken by 200-μm 
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bronze pellets and continuous air flow. To increase the CNT feed to the 
fluidizing bed, additional air flow was used. Since the density of CNT was 
very low, the material reservoir of the FBAG was not large enough to 
accommodate material for a whole 4-h exposure. Thus, the reservoir was filled 
after two hours from the beginning of each exposure. During the experiments, 
the pressure of the exposure chamber differed from the atmospheric pressure 
±200 Pa. The pressure in the chamber was dependent on the experiment flow 
values and on the air intake, whether it was drawn from a room through a 
HEPA filter or from a generator.  
3.2.5 Pharyngeal aspiration (IV) 
The study material was suspended in PBS containing 0.6 mg/ml bovine serum 
albumin (BSA; Sigma-Aldrich, St Louis, MO) and sonicated for 20 min in 
Elmasonic S 15 H water bath sonicator (37 kHz, 35 W; Elma GmbH & Co. 
KG, Singen, Germany). The mice were anesthetized with vaporized 4.5% 
isoflurane and suspended by their incisors on a thin wire on a custom made 
mouse support at approximately 66 degrees angle. A coldlight source was 
placed against their throat to provide optimal illumination of the trachea. The 
tongue was pulled out using blunted forceps and pressed down using a small 
spatula to prevent the mouse from swallowing. A volume of 50 μl of the 
particulate suspension was delivered onto the vocal folds under visual control 
using an extended pipette tip (Finntip 200 Ext, Thermo Fisher Scientific Inc., 
Waltham, MA). Immediately after delivery, the mouse nostrils were covered 
forcing the mouse to inspire the instilled suspension. 
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3.3 In vivo experiment protocols 
3.3.1 Exposure protocol for nanoparticle powders (I) 
There were altogether five exposure groups (eight mice per group). The first 
two groups were exposed once for 2 h and the second two groups were 
exposed for 2 h on four consecutive days, one of the replica groups was always 
sacrificed at 4 h and the other 24 h after the last exposure. The fifth group was 
exposed for 2 h a day on four consecutive days for 4 weeks and sacrificed 24 
h after the last exposure. The exposure concentration was 10 ± 2 mg/m3 in all 
tests. This exposure setting was chosen to mimic occupational conditions 
where workers are exposed to concentrations of around 5 mg/m3 (Boffetta et 
al. 2004). 
3.3.2 The asthma model - sensitization and exposure protocol (II) 
BALB/c/Sca mice were randomized into two exposure and two control groups 
(8 mice/group, table 5). Mice were sensitized intraperitonally with 20 μg of 
ovalbumin (OVA) in alum (Sigma-Aldrich, St Louis, MO) in 100 μl of 
phosphate-buffered saline (PBS) on days 1 and 14 of the experiment (figure  
9). The control group was given alum in 100 μl of PBS. Exposure groups were 
exposed three times a week for 2 hours for the duration of the four week 
experiment, concurrently with the asthma sensitization. The exposure 
concentration was 10 ± 2 mg/m3 in all tests. This concentration was chosen to 
mimic occupational conditions where workers would be exposed to 
concentrations of around 5 mg/m3 (Boffetta et al. 2004). On days 25-27, all 
mice were challenged with 1% OVA solution delivered for 20 min via the 
airways by an ultrasonic nebulizer (DeVilbiss, Glendale Heights, IL). The last 
two exposures were given on days 25 and 27.  Different materials were studied 
on separate occasions. 
Table 5. Mice groups used in publication II. 
Mice groups Not exposed nano TiO2 exp. fine TiO2 exp. 
Healthy (PBS) 8+8 mice 8 mice 8 mice 
Asthmatic (OVA) 8+8 mice 8 mice 8 mice 
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3.3.2.1 Measurement of airway responsiveness (II, III)
In publication II, the airway responsiveness was measured on day 28 using a 
single chamber, whole-body plethysmograph system (Buxco, Troy, NY) as 
described earlier (Hamelmann et al. 1997). Briefly, mice were exposed to 
increasing concentrations (1, 3, 10, 30 and 100 mg/ml) of metacholine (MCh; 
Sigma Aldrich) in PBS delivered via an AeroSonic 5000 D ultrasonic 
nebulizer (DeVilbiss, ITW, Glendale Heights, IL). Before the MCh exposure, 
the baseline was measured for three minutes. After the baseline measurements, 
the MCh was nebulized for 1.5 minutes and airway reactivity was assessed for 
5 minutes per concentration. Lung reactivity parameters were expressed as 
Penh (enhanced pause) values. After measurement of lung responsiveness, the 
mice were sacrificed with an overdose of isoflurane and samples were 
collected for analysis.  
In publication III, the airway responsiveness of BALB/c mice was measured 
on day 5 using a single chamber, whole-body plethysmograph system (Buxco, 
Troy, NY, USA) as described above.  
 
1. BUXCO 
2. Sacrifice 
3. Sample  
         collection 
Day 1 14 2825
Inhalation exposure 3x week for 2h 
OVA ip OVA inh 
Figure 9. Modulation of experimental allergic asthma by nanoparticle exposure. 
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3.3.3 Ex vivo spleen cell stimulations (II) 
The spleens were dissected from the mice onto 6-well plates with PBS. The 
spleens were then mechanically disrupted to form a paste and filtered to 
remove larger pieces. The cells were re-suspended in RPMI media, counted 
under light microscopy and plated at a concentration of one million cells/ml. 
Cells to be stimulated were plated in RPMI containing 100 μg/ml ovalbumin. 
All cells were incubated for 48 hours after which the supernatant was collected 
and stored at -70°C prior to analysis.  
3.3.4 Exposure protocol for fibrous materials (III) 
Mice were exposed to aerosolized rCNT or tCNT for 4 hours at a time once or 
on four consecutive days in a whole-body inhalation chamber. The aerosol 
mass concentrations used for individual experiments were within a range of 
6.2-8.2 mg/m3 for rCNT and 17.5-18.5 mg/m3 for tCNT. A greater 
concentration of control material, (tCNT), was used to confirm that rCNT-
induced inflammatory reactions were rCNT-specific and biologically relevant. 
During the experiments, untreated control mice were housed in the same room 
with CNT-exposed animals. 
3.3.5 Exposure protocol for aspiration (IV) 
In single exposures by pharyngeal aspiration, a dose of 10 μg per mouse (50 
μl of a 0.2 mg/ml dispersion) was used for short –term time points (4 and 16h) 
whereas for the 7, 14 and 28-day exposure, two doses, 10 μg and 40 μg (50 μl 
of a 0.8 μg/ml dispersion), per mouse were used. The doses were selected to 
mimic occupational conditions (Porter et al. 2010).  
3.3.5.1 Antagonists (IV) 
In the antagonist experiment, intraperitoneal injections were delivered and 16 
h later the mice were subjected to the pharyngeal aspiration (table 6). The 
animals were sacrificed at 4 h after the aspiration exposure. PBS contained 0.6 
mg/ml BSA, 10 μg of R/CNT was given per mouse (0.2 mg/ml dispersion) 
and the mice were treated with antagonists, either anakinra (Kineret; 
Biovitrum AB, Stockholm, Sweden) or etanercept alone or in combination 
(Enbrel; Wyeth Pharmaceuticals, Hampshire, UK) 200 μg/mouse both times. 
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Table 6. Exposure groups of the antagonist experiment. 
intraperitoneal injection pharyngeal aspiration  
PBS/BSA PBS/BSA 
PBS/BSA PBS/BSA + R/CNT 
PBS/BSA + etanercept PBS/BSA + R/CNT + etanercept 
PBS/BSA + anakinra PBS/BSA + R/CNT + anakinra 
PBS/BSA + etanercept + anakinra PBS/BSA + R/CNT + etanercept + anakinra 
 
3.4 In vitro experiments 
3.4.1 Cell lines (I) 
Murine macrophage RAW 264.7 and human pulmonary fibroblast MRC-9 
cells were purchased from the American Type Culture Collection (Manassas, 
VA). RAW 264.7 cells were cultured in RPMI 1640 medium (Invitrogen, 
Carlsbad, CA) and MRC-9 cells in MEM + GlutaMAX-1 medium (Invitrogen) 
supplemented with 10% of heat-inactivated fetal bovine serum, 1% penicillin-
streptomycin (PEST) antibiotics, L-glutamine, 1× nonessential amino acids, 
and 1× Na-pyruvate. All cells were cultured at + 37°C in 5% CO2.  
3.4.2 Differentiation of macrophages from peripheral blood–derived 
monocytes (I) 
The peripheral blood–derived monocytes were isolated from the buffy coats 
by Ficoll-Paque gradient centrifugation after which the mononuclear cell layer 
was harvested. After washing the harvested cells three times with PBS (pH 
7.4), the mononuclear cells were allowed to adhere onto six-well plates (10 
million cells per well) for 50 min covered in RPMI 1640 medium 
supplemented with 2mM L-glutamine and 1% PEST at 37°C and an 5% CO2 
atmosphere. The cells were then washed three times with PBS. After the last 
wash, the adhered cells were given 1 ml serum-free macrophage medium 
(Invitrogen) supplemented with granulocyte-macrophage colony–stimula t ing 
factor (ImmunoTools, GmbH, Germany) 10 ng/ml and 1% PEST. The 
macrophage medium was changed every second day. Maturated macrophages 
were used for stimulations on the seventh day after the cell harvesting. All cell 
stimulations were done using cells obtained from three different blood donors. 
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The phenotype of these macrophages resembles closely that of human alveolar 
macrophages (Akagawa et al. 2006).  
3.4.3 Exposure protocol (I) 
One day before the exposures, all the cells were provided with fresh medium. 
The cells were exposed with medium containing the desired amount of the 
nanoparticles, which had been beforehand sonicated for 20 min in Elmasonic 
S 15 H water bath sonicator (37 kHz, 35 W; Elma GmbH & Co. KG, Singen, 
Germany) before delivering it to the cells. Lipopolysaccharide (Escherichia 
coli O111:B4; Sigma-Aldrich) was used as a positive control at a 
concentration of 100 ng/ml. Tumor necrosis factor-alpha (TNF-α) was from 
BioSource International (Camarillo, CA), and the concentration used was 10 
ng/ml.  
3.5 Sample collection and analyses 
3.5.1 Collection of in vivo samples and preparation (I, II, III, IV) 
The mice were sacrificed using an overdose of isoflurane. Blood was collected 
from the vena cava (hepatic vein), and the lungs were lavaged with PBS (800 
μl for 10 s) via the tracheal tube. The bronchoalveolar lavage (BAL) sample 
was cytocentrifuged on a slide, and later, the cells were stained using the May 
Grünwald-Giemsa (MGG) stain and counted under light microscopy. The 
BAL supernatant was stored at −70°C for cytokine analysis, and the remaining 
cells were fixed in 1:1 ethanol-DPBS mixture. The blood was kept on ice and 
later centrifuged. The supernatant was then collected and kept at −70°C for 
subsequent analysis. The mouse chest was opened and half of the left 
pulmonary lobe was removed, quick-frozen, and kept at −70°C for later RNA 
isolation. A slice of the lungs and BAL cells were collected from each mouse, 
fixed with glutaraldehyde, and then prepared for electron microscopy. A part 
of the left lobe was embedded in Tissue-Tek oxacalcitriol compound (OCT, 
Sakura Finetek, Alphen aan den Rijn, Netherlands), quick-frozen and kept at 
-70 ºC for later immunohistochemical staining. (IV) The rest of the lungs were 
formalin fixed, embedded in paraffin, cut, affixed on slides, and stained with 
hematoxylin and eosin (H&E), Periodic acid-Schiff (PAS) and picrosirius red 
(PSR, III) solutions.  
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3.5.2 Histology 
3.5.2.1 Analysis of mucus producing cells (II, III) 
The lung tissue was analyzed from formalin-fixed, paraffin-embedded 
sections. These sections were stained for mucus secreting goblet cells using 
periodic acid-Schiff (PAS) -stain. The data was analyzed with Leica Image 
Manager IM50 version 4.0 (Leica Microsystems Imaging Solutions Ltd., 
Cambridge, UK). PAS+ cells were counted as an average of PAS+ cells found 
in 100 μm (I) or 200 μm (II)  of bronchus counted from three bronchioles of 
similar size per mouse (n = 8 mice per group).  
3.5.2.2 Lung morphology (III) 
Recruitment of inflammatory cells into the lungs and morphologica l 
alterations of the tissue were assessed after H&E staining. Lung sections  
stained with PSR solution were used to evaluate the formation of fibrosis but 
also the distribution of CNT within lungs since these black fibers were easily 
detectable against the light background. 
3.5.3 Bronchoalveolar lavage cells (I, II, III, IV) 
MGG-stained BAL cells were counted from three high-power fields in a light 
microscope (Leica DM 4000B; Leica, Wetzlar, Germany). 
3.5.4 mRNA analyses 
3.5.4.1 RNA isolation from the lung tissues (I, II, III, IV) and cultured cells 
(I) 
Due to the very local mode of action of cytokines and chemokines, they are 
known to circulate in the organism at very low levels (<10 pg/ml) and used   
rapidly by the cells. (Bienvenu et al. 2000) Therefore cytokines and 
chemokines especially from the in vivo studies are often below the detection 
limit of many protein assays.  In an attempt to avoid possible false negative 
results, it was decided to focus on the key cytokines/chemokines and to assess 
them via their mRNA expression levels using quantitative RT-qPCR  which  
is  a  more  rapid  and  sensitive  method  compared with protein analysis. 
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The lung samples were homogenized in a FastPrep FP120 (BIO 101; Thermo 
Savant, Waltham, Mass) machine, and RNA was extracted using the FastRNA 
Pro Green Kit (Qbiogene/MP Biomedicals, Illkirch, France) according to 
recommendations of the manufacturer. The quantity and purity of extracted 
RNA was determined by NanoDrop spectrophotometer (ND-1000; NanoDrop 
Technologies, Inc., Wilmington, DE). Isolated total RNA was dissolved in 
diethyl pyrocarbonate (DEPC) water and stored at −70°C.  
Before RNA isolation from the cells, the nanoparticles were removed from the 
solution by centrifuging the samples at 14,000 × g 10 min + 4°C. At this point, 
the triplicate samples of human macrophages were pooled. Total RNA from 
cultured cells was isolated by phenol-chloroform method with Eurozol reagent 
(EuroClone S.p.A-Life Sciences Division, Siziano, Italy) according to the 
manufacturer’s instructions and precipitated with isopropanol. Total RNA was 
dissolved in DEPC-treated milli-Q water.  
3.5.4.2 Complementary DNA synthesis (I, II, III, IV) 
Complementary DNA (cDNA) was synthesized from 1 μg of total RNA in a 
25 μl reaction using MultiScribe Reverse Transcriptase and random primers 
(The High-Capacity cDNA Archive Kit; Applied Biosystems, Foster City, 
CA) using the manufacturer’s protocol. The synthesis was performed in a 2720 
Thermal Cycler (Applied Biosystems, Carlsbad, CA) starting with 25°C for 
10 min and continuing with 37°C for 120 min.  
3.5.4.3 PCR amplification (I, II, III, IV) 
PCR primers and probes were ordered as predeveloped assay reagents from 
Applied Biosystems. The real-time quantitative PCR was performed in a 96-
well optical reaction plate with Relative Quantification 7500 Fast System 
(7500 Fast Real-Time PCR system; Applied Biosystems) using the 
manufacturer’s instructions. Amplifications were done in 11 μl reaction 
volume containing 20 ng cDNA and TaqMan universal PCR master mix and 
primers provided by Applied Biosystems. Endogenous 18S was used as the 
housekeeping gene.  
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3.5.5 Protein analyses 
3.5.5.1 Enzyme-linked immunosorbent assay (I, II, IV) 
ELISAs (eBioscience, San Diego, CA) were performed according to the 
manufacturer’s instructions. An ELISA plate microtiter reader (Multiskan MS, 
Labsystems, Helsinki, Finland) was used to read the results.  
3.5.5.2 Luminex (IV) 
The Milliplex Mouse Cytokine/Chemokine Immunoassay was used in the 
analysis of proteins in BAL fluid supernatants (Millipore Corporation, 
Billerica, MA) according to the manufacturer’s protocol. Then, 3% bovine 
serum albumin (BSA; Sigma-Aldrich, St Louis, MO) in PBS was added at a 
concentration of 0.5% to samples, controls and standards to ensure suffic ient 
protein amounts for the assay. The assay was performed using Luminex xMAP 
Technology (Bio-Plex 200 System, BioRad, Hercules, CA). 
3.5.6 Measurement of serum antibodies (II) 
For the analysis of OVA-specific IgE, ELISA plates were coated with Purified 
Rat Anti-mouse IgE antibody (BD Biosciences, San Jose, CA) and incubated 
overnight. On the second day, the plates were blocked with 3% BSA in PBS, 
serum samples (1:10 and 1:20 dilution) were added to the plate and incubated 
overnight. Biotinylated OVA was added and streptavidin horseradish 
peroxidase (Pharmingen 13047E, BD Biosciences) followed by ABTS 
solution (ABTS Microwell Peroxidase Substrate System, KPL, Gaithersburg, 
MD). Absorption was read at 405 nm with ELISA plate absorbance reader 
(Multiskan MS, Labsystems, Helsinki, Finland).  
For OVA-specific IgG2a analysis, ELISA plates were coated with ovalbumin 
(BD Biosciences) and incubated overnight. On the second day, the plates were 
blocked with 3% BSA in PBS, serum samples (1:60, 1:180, 1:540 and 1:1620 
dilution) were added to the plate and incubated overnight. Biotinylated anti-
mouse IgG2a (Pharmingen 02012 D, BD Biosciences) was added and 
streptavidin horseradish peroxidase (BD Biosciences). ABTS solution and 
peroxidase were mixed 50:50 and added before reading absorption at 405 nm 
with an ELISA plate absorbance reader.  
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3.5.7 DNA microarrays (III) 
Total RNA samples isolated from lung tissue as described above were 
quantified by NanoDrop and the quality was verified by Agilent Bioanalyzer 
2100 (Agilent Technologies, Santa Clara, CA, USA). Independent pools of 
two RNA samples each (total of 600 ng) were labeled using a T7 RNA 
polymerase amplification method (Low Input Quick Amp Labeling Kit, 
Agilent Technologies), according to the instructions of the manufacturer. 
cRNAs were then labeled with Cy3 and Cy5 dyes (Agilent Technologies) and 
hybridized to the Agilent 2-color 60-mer oligo arrays (Agilent SurePrint G3 
Mouse GE 8x60K). The slides were washed and scanned with Agilent 
Microarray Scanner G2505C (Agilent Technologies) and the raw intens ity 
values were obtained with the Feature Extraction software, version 11.0.1.1 
(Agilent Technologies). Raw data was quality checked according to the 
Agilent standard procedures. The median foreground intensities were 
imported into the R software version 3.0.0. (http://cran.r-project.org)(Team 
2012) and analyzed with the BioConductor package limma. (Smyth 2005)  
Log2 transformation and quantile normalization was performed on the single 
channel data separately, similarly to published methods (Kilpinen et al. 2013, 
Palgi et al. 2012, Procaccini et al. 2012) and according to the proposals by 
Smyth and Altman (Smyth et al. 2013). No background correction was carried 
out, as suggested by Zahurak et al. (Zahurak et al. 2007)  Subsequently the 
batch effect derived from the labeling was removed using the ComBat method 
(Benjamini et al. 1995) implemented in the sva package. (Johnson et al. 
2007),(Leek et al. 3.6.0 )  The values of the probes recognizing the same NCBI 
Entrez Gene Ids (Coordinators 2013) were further averaged into the final 
expression matrix. Differentially expressed genes were identified by using 
linear models and empirical Bayes pairwise comparisons (post hoc adjusted 
P<0.01 and linear FC > |1.5|).(Smyth 2004) The resulting gene sets after 
Benjamini and Hochberg post hoc correction (Benjamini et al. 1995) were 
considered to be significant and were studied further by the DAVID version 
6.7 annotation tool (Huang 2009) with the default parameters. 
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3.5.8 Electron microscopy (I, IV) 
Samples were fixed in 2.5% glutaraldehyde and postfixed in 1% osmium 
tetroxide, dehydrated and embedded in epon (I) or LX-112 (IV) (Ladd 
Research, Williston, VT, USA). Thin sections were collected on uncoated 
copper grids, stained with uranyl acetate and lead citrate and then examined 
with a transmission electron microscope operated at 80 (I) or 100KV (IV) 
(JEM-1220, Jeol Ltd., Tokyo, Japan) and photographed with a Veleta TEM 
CCD camera (Olympus Soft Imaging Solutions Gmph, Germany). 
3.5.9 Immunohistochemical staining (IV) 
The frozen OCT-fixed lung tissue samples were cut into 4 μm thick slides, air-
dried and fixed with -20C acetone for 10 minutes and then stained with the 
Autostainer 360 (Thermo Scientific) using primary antibodies CD3 (clone 
17A2, BD Pharmingen, San Diego, CA), CD4 (clone RM4-5, BD 
Pharmingen), CD8 (clone 53-6.7, BD Pharmingen), CD11c (clone HL3, BD 
Pharmingen) and F4/80 (clone BM8, Acris Antibodies GmbH, Herford, 
Germany). Positive cells were counted under light microscopy at x400 
magnification as an average of at least 5 randomly selected areas of 2 sections.  
3.5.10 Inductively coupled plasma-mass spectrometry (I) 
The titanium concentration of the lung tissues was analyzed from the formalin-
fixed lungs by inductively coupled plasma-mass spectrometry (ICP-MS, 
Thermo X series II, Thermo Electron, Bremen, Germany). The samples were 
dried to constant weight, the organic material was combusted with acids, and 
the titanium concentration was measured by ICP-MS using germanium as an 
internal standard. 
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3.5.11 Statistical analysis (I, II, III, IV) 
The toxicological data were analyzed and the graphs were created with the 
GraphPadPrism software (GraphPadPrism Software, Inc., San Diego, CA). In 
all statistical analyses, first analysis of variance was performed using one-way 
ANOVA (nonparametric Kruskal-Walles test) and when the ANOVA was 
positive, then appropriate post-hoc tests were performed. The different groups 
were compared using an unpaired t-test or nonparametric Mann-Whitney U-
test, and p values less than 0.05 were considered statistically significant. 
Regression analyses and calculations of probabilities in the analysis of ·OH 
radical formation were done using the standard equations in MS Office Excel 
versus 2003 and Minitab 15 1.0.0 (Minitab Inc., State College, PA).  
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The results summarized in table 7 before, are described in more detail in the 
following chapters. 
4.1 Effects of inhalation exposure to different TiO2 (I) 
This original publication revealed that even a material that is thought to be 
inert and safe, after small modifications, can become harmful. Here, four 
different nanosized TiO2 (one coated with SiO2, cnTiO2), coarse TiO2 and 
nanosized SiO2 were compared. Out of these six materials, only the cnTiO2 
evoked inflammation in the lungs of the mice after one week’s inhala t ion 
exposure. The presence of pulmonary neutrophilia (I, Fig. 2a) was confirmed 
by the expression of the neutrophil-attracting chemokine CXCL1 (I, Fig. 3b) 
and the major pro-inflammatory cytokine TNF-α (I, Fig. 3b). 
 
The mRNA results from in vivo studies suggested that macrophages were the 
main producers of TNF-α and lung cells of neutrophil-attracting chemokines. 
This was further verified using murine alveolar macrophages (RAW 264.7) 
and monocyte-derived human macrophages. Both macrophages were 
identified as a major source of the pro-inflammatory cytokine TNF-alpha (I, 
Fig. 5a,b and 6a) after exposure to cnTiO2. Human lung fibroblasts (MRC-9) 
on the other hand were exposed to cytokines secreted by cnTiO2-exposed 
macrophages, which resulted in a strong expression of CXCL1 and CXCL8.  
 
Analyzing the lung tissues revealed that particles accumulated mainly in the 
phagosomes of pulmonary macrophages (I, Fig. 4a). In contrast to the other 
particles, cnTiO2 particles seemed to be free in the cytosol, suggesting that 
they had broken out of the phagosomes and been released into the cytoplasm 
(I, Fig 4c). 
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4.2 Effects of inhalation exposure to nanosized and fine TiO2 on 
allergic asthma (II) 
This study revealed important results emphasizing the heterogeneity of the 
human population. Here healthy and asthmatic mice were exposed to 
nanosized (n) and fine (f) TiO2 for three times a week for four weeks. A murine 
asthma model was used to mimic reactions in a more vulnerable part of the 
population.  As seen in the previous study, exposure of healthy mice to nTiO 2 
(same as cnTiO2 in the previous study) resulted in clear pulmonary 
neutrophilia (II, Fig. 3) and an induction of neutrophil-attracting chemokine 
CXCL5 (II, Fig. 7b).  
 
Eosinophilia (II, Fig. 3), lymphocytes (II, Fig. 3) and the expression of mucus 
secreting PAS+ cells (II, Fig. 4), all known features of allergic asthma, were 
dramatically down-regulated in both TiO2 exposed mice. All measured cell 
signaling molecules, including pro-inflammatory (II, Fig. 6a), regulatory (II, 
Fig. 6c) and Th2-type cytokines (II, Fig. 6b), were up-regulated in the 
asthmatic mice, but were similar to levels found in healthy mice in both TiO2 
exposed groups. The same was true for all measured chemokines (II, Fig. 7).  
 
Airway hyper-responsiveness, a hallmark of allergic asthma, revealed a 
difference in the two TiO2 materials - while nTiO2 reduced responsiveness (II, 
Fig. 5a), fTiO2 showed a modest exacerbation of this asthmatic symptom (II, 
Fig. 5b). Finally, the results obtained with OVA-stimulated ex vivo spleen cells 
pointed to a systemic immune suppression after exposure to nTiO2 (II, Fig. 8) 
while fTiO2 reduced levels of OVA-specific IgE (II, Fig. 9a).  
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4.3 Unconventional allergic-like airway inflammation evoked by 
inhalation exposure to CNT (III) 
The aim of this study was to compare two differently shaped carbon 
nanotubes, flexible tangled and rigid rod-like CNT. Mice were exposed by 
inhalation for four hours a day once or on four consecutive days. The focus of 
this study was on early events with the mice being sacrificed immediately and 
24 hours after a single exposure. The four day exposure mimicked an 
occupational week.  Mast cell deficient mice were used to examine the role of 
mast cells in the inflammation and the transcriptomics analysis was used to 
explore the early transcriptional responses, which may play an important role 
in initiating the airway inflammation. 
 
It was found that even a short-term inhalation of the rod-like CNT (rCNT) was 
able to induce a novel allergic- like inflammation mediated by the innate 
immunity. This inflammation was characterized by pulmonary eosinophil ia  
(III, Fig. 1b) and relevant chemokines (III, Fig. 2g), mucus hypersecretion (III, 
Fig. 2b,d), airway hyper-reactivity (III, Fig. 2a) and Th2-type cytokines (III, 
Fig. 2e). All of the above mentioned responses are considered as hallmarks of 
allergic asthma.  
 
Mast cells are thought to act as major mediators in immediate allergic reaction. 
These cells were found to partially regulate the allergic- like inflammation 
caused by rCNT.  Using mast cell deficient KitW-sh mice and the four day 
exposure routine, the mast cells were shown to mediate eosinophilia (III, Fig. 
3a) and the production of IL-13 (III, Fig. 3c). 
 
Transcriptomics analysis was used to identify early molecular events taking 
place in the resident cells, which finally result in allergic-like airway 
inflammation seen after four days of rCNT exposure. Immediately after the 4 
hour rCNT exposure, the pathways induced were almost exclusively related to 
innate immunity (III, Fig. 4c). On the contrary, this phenomenon was not 
found with tCNT (III, Fig. 4c).  
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Next, cytokine and chemokine expression were compared in alveolar 
macrophages, resident lung cells and mast cells using BAL, lung tissue and 
mast cell deficient mice respectively. It was found that pro-inflammatory 
cytokine IL-1β and TNF-α were mainly produced by alveolar macrophages 
(III, Fig. 5a) and IL-13 and IL-4 by mast cells (III, Fig. 5c). 
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4.4 A Th2-type pulmonary inflammation resulting from 
aspiration exposure to CNT (IV) 
This study utilized a different exposure technique, pharyngeal aspiration, 
which permits the use of more time points and doses as well as a more precise 
dosage when compared to inhalation. It is also a safer method to use with 
hazardous materials. The same two CNT as examined in the previous study 
were examined but in addition, crocidolite asbestos was included as a control 
material of interest. Doses of 10 or 40 μg per mouse were administered and 
the mice were sacrificed at 4 or 16 hours or 7, 14 and 28 days after a single 
exposure. 
 
At 4 hours after exposure, the mRNA expression of neutrophil attracting 
chemokine CXCL1 was observed with all materials (IV, Fig. 1c). There was 
also evidence of pulmonary neutrophilia in all groups and this increased in a 
time-dependent manner from 4 to 16 hours, with the rod-like CNT (R/CNT) 
eliciting the fastest and highest reaction (IV, Fig. 1a). R/CNT alone induced 
the mRNA expression of pro-inflammatory cytokine IL-1β and lymphocyte 
attractant CXCL9 at the 4 hour point (IV, Fig. 1b, d).  
 
At 7 days after exposure, there was a drastic shift in the influxing cells as the 
numbers of neutrophils had diminished whereas a strong eosinophilia was 
present in the R/CNT and asbestos exposed groups (IV, Fig. 9b, c). R/CNT 
also elicited strongest mRNA expression of IL-1β, TNF, TGF-β, CCL11 and 
CCL24 and increase in numbers of goblet cells (IV, Supplementary Fig.2c, 
3a-d). 
 
At 14 days, it was possible to detect Charcot-Leyden-like crystals in R/CNT 
and asbestos exposed mice. At this time point, the numbers of eosinophils had 
significantly reduced (IV, Fig.9). The numbers of mucin-producing goblet-
cells had however still increased when compared to day 7 (IV, Supplementary 
Fig.5). 
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After 28 days, the strong effect of R/CNT remained as there were still up-
regulated mRNA levels of pro-inflammatory cytokines TNF-α and IL-1β (IV, 
Fig. 2d,e) and clear signs of pulmonary neutrophilia (IV, Fig. 2a). At this time, 
eosinophilia had disappeared completely (IV, Fig.9). Instead pro-fibrotic 
TGF-beta levels remained high (IV, Fig. 2f). The effects of asbestos and 
tangled CNT (T/CNT) had either disappeared, or in the case of TGF-beta, were 
even down-regulated. 
 
Other changes observed at the later time point included interstit ia l 
macrophages around R/CNT fibers and bundles (IV, Fig. 3a-b), granulomas 
(IV, Fig. 4a), acidophilic macrophages containing Charcot-Leyden- like 
crystals (IV, Fig. 5a-c), mucus hypersecretion (IV, Fig. 6a) and up-regulated 
mRNA expression of Th2 type cytokine IL-13 (IV, Fig. 6c). Asbestos and 
T/CNT also caused some of these changes, but to a much smaller degree.   
 
The role of a major pro-inflammatory player IL-1β was studied together with 
its close companion TNF-α using antagonists and IL-1-receptor knock-out 
(KO) mice. At 4 hours, both antagonists, anakinra (IL-1β) and etanercept 
(TNF-α), given either together and separately abolished mRNA expression of 
IL-1β and TNF-α as well as abolishing the neutrophilia (IV, Fig. 7a). This was 
in line with results from KO mice, where the levels of neutrophils and 
neutrophil attracting chemokines CXCL5, 1 and 2 were significantly down-
regulated when compared to wild type (WT) mice (IV, Fig. 7b). At 28 days, 
the KO mice showed continuous impairment in terms of neutrophilia and the 
expression of TNF-α mRNA (IV, Fig. 8a,e). Th2-related signals, IL-13 and 
mucus production, as well as pro-fibrotic TGF-β however remained unaffected 
(IV, Fig. 8f-g). 
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5 DISCUSSION 
As nanomaterials have become increasingly common and product 
development on ENM is more intensive than ever, it is crucially important that 
research should be conducted into the safety of these materials. The tragedy 
surrounding asbestos, a material responsible for so many deaths following its 
widespread use, is often highlighted as a warning example of how apparently 
safe materials can be incredibly dangerous. This time with ENM, we should 
be wise ahead of time, to avoid another asbestos disaster.  As researchers in 
the nanosafety field have come to realize, the task is not as easy as one would 
think. The number of different materials is increasing every day and even a 
small modification can dramatically change how a material reacts with the 
human body. Ultimately this means that it is extremely hard to draw a 
demarcation line between a safe and a harmful material. As a result, to be 
guaranteed safe, each material should be studied on its own or treated as a 
potentially harmful material. The work conducted to evaluate the safety of 
ENM in this thesis have definitely proven that even if you think you know 
how a material will react, you will most likely be surprised. 
5.1 TiO2 nanoparticles – harmful, neutral or healing ENM? 
As larger particles, TiO2 have long been used as a negative control. However 
when nanosized particles entered the market, this situation changed. At 
present, nTiO2 has been rather extensively investigated in different in vivo and 
in vitro models. nTiO2 has been demonstrated to evoke both local and systemic 
symptoms and also to aggravate pre-existing symptoms (Li et al. 2013, Zhang 
et al. 2015). In addition to the lungs, other exposure routes have been less 
extensively studied, but should not be forgotten. nTiO2 are the most commonly 
used nanoparticle in dermally applicable consumer products (Robertson et al. 
2010) and present in many orally administered items such as food colorants 
and nutritional supplements. They are also used as carriers in nanomedic ine s 
that may be administered intravenously or subcutaneously. It has been shown 
that nTiO2 can be absorbed through the lungs and GIT into the systemic 
circulation and because of this possibility, other organ injuries and 
inflammatory reactions should be investigated. Continual use may lead to 
chronic levels of exposure and accumulation in many organs. Most nTiO2  
studies have employed doses that are not realistic in occupational settings and 
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as such, extrapolation to human exposures can be difficult (Shakeel et al. 2015, 
Shi et al. 2013). 
 
The results from publications I are in line with common observation of nTiO 2  
(Li et al. 2013, Sha et al. 2015, Zhang et al. 2015). In publication I, it was 
concluded that most nTiO2 are rather harmless, when the exposure is to modest 
doses. At least doses under the two recommended levels (0.3 mg/m3 by 
NIOSH, (Dankovic et al. 2011) and 1.2 mg/m3 by NEDO, (Morimoto et al. 
2010)) can with ease be considered modest. In a recent study by (Spinazzè et 
al. 2016) worker exposure levels remained at 300 μg/m3 and in another recent 
study also well below the RELs (Vaquero et al. 2015). If then exposures of 10 
mg/m3 result in only modest inflammation, following RELs in occupationa l 
settings can well be presumed safe. 
 
In the acute TiO2 exposures of this thesis, the materials used did not provoke 
any notable reactions in the mouse lungs. Only the SiO2 coated nTiO2 (cnTiO2) 
caused pulmonary inflammation after four days of exposure causing 
neutrophilia, high mRNA levels of pro-inflammatory TNF-α and the 
neutrophil attracting compound, CXCL1. The results after four weeks 
remained at the levels close to those observed after one week, indicating that 
the body was able to clear the particles and the inflammation levels remained 
somewhat stable. If the particles hadn’t been cleared at all, they would have 
been accumulating in the lungs and thus likely been increasing the 
inflammatory reaction. Results from ICP-MS analyses confirmed that the 
clearance rate indeed was around 60%. Four weeks of exposure to coarse TiO2  
on the contrary did not cause signs of inflammation.  
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An inflammatory cascade was also proposed for the SiO2 coated TiO2 (figure  
10) which started with alveolar macrophages engulfing SiO2 coated TiO2  
particles into their phagosomes. After phagosomal entrapment, SiO2 coated 
TiO2 seemed to emerge into the cytoplasm, possibly causing the release of 
TNF-α from the macrophages, which in turn caused the release of CXCL1 
mRNA from the epithelial cells leading to pulmonary neutrophilia. This was 
also supported by in vitro data obtained from human and murine macrophages 
and human lung fibroblasts. Since neither plain SiO2 nor TiO2 caused the 
observed effects, it is likely that coating TiO2 with SiO2 caused the material to 
convert from being inert to harmful. In an intratracheal instillation study done 
in mice, (Saber et al. 2012) also concluded that two coated TiO2 were more 
harmful than an uncoated one. On the other hand coating can also reduce 
toxicity as was concluded in an in vitro study by (Tedja et al. 2012). There the 
surface adsorbed serum components were found to provide some protection 
from the cytotoxic effect of endocytosed TiO2 nanoparticles.    
 
ALVEOLAR  
MACROPHAGE 
TiO2 (SiO2 coated) 
CXCL1 
IL-1β 
NEUTROPHILS 
EPITHELIAL CELLS 
Figure 10. Possible 
inflammatory cascade 
caused by cnTiO2. 
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It would be interesting to find out what causes SiO2 coated TiO2 to be released 
from the phagosomes as was seen in publication I. It was speculated in the 
publication that it had something to do with the material’s Z-potential. 
Interestingly, in a publication about several different silica nanopartic le 
exposures on macrophages it was suggested that the IL-1β responses induced 
by the particles in the RAW264.7 macrophages involved activation of the 
vacuolar H+-ATPase, and induction of cathepsin B release, subsequently 
leading to phagosomal destabilization (Sandberg et al. 2012). (Palomäki et al. 
2010) studied immunological effects of SiO2 coated TiO2 on antigen 
presenting cells (APC, e.g. RAW264.7) in vitro and found that the material 
elicited a very slight increase in expression of IL-1β and in addition 
expressions of IL-6, MIP-1α and TNF-α. If not through this exact pathway, 
then possibly through something similar, the SiO2 coated TiO2 causes 
phagosomes to break. 
 
In publication II, a murine model was used to assess effects of nTiO2 exposure 
on asthmatic and non-asthmatic mice. The same nTiO2 was used as in 
publication I (referred to as cnTiO2 in that article). This was compared to a 
larger TiO2, referred to as fTiO2. The working hypothesis was that there would 
be exacerbation of the allergic inflammation, but on contrary, most markers of 
inflammation were reduced due to TiO2 exposure. Known signs of asthma: 
eosinophilia, lymphocytes, mucus production and relevant mRNA of 
cytokines IL-1β, TNF-α, IL-4, IL-13 and chemokine CCL3, were all down-
regulated in nano- and finesized TiO2 exposed groups. The two different sizes 
of TiO2 differed in the measured AHR, i.e. fTiO2 caused a slight increase 
whereas nTiO2 followed the suppressive trend. Another difference between 
these materials was the reduced level of IgE-antibody following fTiO2 
exposure, but not nTiO2. It was hypothesized that many particles that cause 
exacerbation of asthmatic symptoms also contain organic matter and as such, 
also contain pathogen-associated molecular patterns (PAMP) that activate 
innate immunity. It is possible that the lack of this PAMP-signal had prevented 
the symptoms from developing. This would however only explain why the 
symptoms did not become more severe, but it gives no clear clues as to why it 
seemed as if the asthma-like symptoms were disappearing. In an article by 
(Whitehead et al. 2014) it was shown that inhalation of moderate doses of LPS 
DISCUSSION 
59 
 
during sensitization induces regulatory responses that, after multiple allergen 
exposures, limit the severity and longevity of asthma-like features. In this case 
a plain PAMP-signal inhibits asthmatic inflammation. 
 
Available research shows that similar to immunostimulation, nanopartic le-
mediated suppression and inhibition of immune function exists in some cases 
and is determined by the nanoparticle's physicochemical properties (Ilinskaya 
et al. 2014). In case of TiO2 significant immunosuppression in vivo has been 
shown e.g. when systemic administration of nTiO2 inhibited T-cells, B-cells, 
macrophages and NK cells in one study (Andersson-Willman et al. 2012) and 
in another study exposure was associated with greater susceptibility to a 
melanoma challenge (Moon et al. 2011). 
 
While one could speculate that inhaling TiO2 particles would be a cure for 
asthma, unfortunately this is most likely not the case. One possible explanation 
is that the sensitization phase is strongly modulated by the concurrent 
exposure to TiO2 and that the particles cause a competing pro-inflammatory 
response, which in some unknown manner overwhelms the Th2 response. This 
could be true for the nTiO2, but as fTiO2 seems to be quite neutral by itself, it 
does not explain how both materials are able to block most asthmatic 
responses. This does however leave the option that the modulation is a result 
of some underlying mechanisms that are activated by both types of TiO2 
exposure, but only cause inflammation in the case of the more irritant material, 
the nTiO2. An interesting study done on OVA-sensitized rats showed that 
allergic pulmonary inflammation is not up-regulated by inhalation of 
nanosized TiO2, but on the contrary decreases lung inflammation (Scarino et 
al. 2012). They speculated that the inhibition might be due to the route of 
exposure (inhalation) or the timing of the nanoparticle exposure in relation to 
the induction of the asthmatic lung inflammation. Their single exposure was 
performed subsequent to the allergen challenge. The OVA-challenges in 
publication II were given on three concurrent days and TiO2 exposures on first 
and last of those days. Exposures were however also given many weeks in 
advance. Results in a mouse model of di-isocyanate- induced asthma show in 
contrast that low, intrapulmonary doses of nTiO₂ can aggravate pulmonary 
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inflammation and AHR (Hussain et al. 2011).  Plain silica on the other hand 
has been shown to exacerbate OVA-induced allergic airway inflammation in 
mica and to exert adjuvant effects (Han et al. 2016).  
 
In conclusion, it seems that nanosized TiO2 are able to cause moderate toxicity 
which in case of allergic asthma seems to suppress the Th2-type immune 
reaction. Toxicity is most commonly seen as pulmonary inflammation and 
according to the literature (Dankovic et al. 2011, Shi et al. 2013), nanosized 
TiO2 are generally able to induce greater responses than their larger 
counterparts. In addition to inflammation, other studies show production of 
reactive oxygen species (ROS) leading to increased oxidative stress levels, 
histopathological alterations, genotoxicity, metabolic chance, carcinogenes is 
and immune disruption. As seen also in the present studies, the extent of the 
damage depends on material-based characteristics such as crystal structure, 
size and purity of the TiO2 (Fedora et al. 2016, Shakeel et al. 2015, Shi et al. 
2013).  
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5.2 Rigid long MWCNT – a close cousin of asbestos 
In light of growing evidence about the possible toxicity of CNTs and on the 
other hand their great commercial potential, especially in electronics and 
medicine, it is not surprising that controversy surrounds these impressive 
materials. It seems that there is some validity in comparing this material to 
asbestos, however the heterogeneity of the CNT leaves many questions 
unanswered. 
 
Publication III demonstrated that the shape and length of a MWCNT could 
greatly affect its toxicity. In this study, the rigid rod-like material (rCNT) 
resembling asbestos fibers in terms of shape, and slightly in size, caused a 
dramatic pulmonary inflammation with many characteristics similar to allergic 
asthma, while this was not observed with a tangled CNT (tCNT). In agreement 
with the present studies, it has been shown across the CNT field that the 
toxicity of CNT is mainly length dependent. There is convincing evidence that 
short or tightly bundled aggregates with no isolated long fibers are less 
inflammogenic in fiber-specific assays (Osmond-McLeod et al. 2011). 
However, short 5μm MWCNT may also be pro-inflammatory if delivered in 
high bolus doses or as large aggregates (Kolosnjaj-Tabi et al. 2010, 
Oberdörster et al. 2015). In addition to the length of the fiber, also its metal 
content/purity, rigidity, reactivity, diameter, surface and crystal structure may 
play some roles in defining the overall toxicity (Boyles et al. 2015, Wang et 
al. 2013, Vietti et al. 2016).  
 
Macrophages have a major role in CNT induced toxicity as the key problem 
seems to be frustrated phagocytosis, leading to the continued production of 
pro-inflammatory cytokines and reactive oxygen species (ROS) as a result of 
the phagocytic burst.  Macrophages were first-line responders also in the 
present studies, trying to engulf the foreign material, resulting in incomplete 
phagocytosis, carbon bridges being formed between macrophages and foreign 
body giant cells (FBGC) after exposure to rCNT. Macrophages were also 
shown to express pro-inflammatory cytokines IL-1β and TNF-α. In addition 
to frustrated phagocytosis, long fibers have been shown to induce 
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inflammation should they accumulate in the parietal pleura. This is due to the 
size of the lymphatic stomata, which are about 8-10μm, allowing only smaller 
fibers to pass (Donaldson et al. 2010). In addition to macrophages, other 
strongly responding cells included eosinophils and mucus producing cells that 
both appeared in great numbers after rCNT exposure.   
 
As foreign body giant cells, eosinophils and mucus production indicated a Th2 
type inflammation, other signs of allergic asthma were also sought. The 
expression of Th2 cytokines, AHR and also eosinophil chemoattractants were 
studied. In a more detailed search for other allergic mediators, mast cells were 
examined and it was found that they were indeed participating in the rCNT 
induced allergic- like airway inflammation, at least by producing IL-4 and IL-
13. However, this allergic- like inflammation was unusual due to the short 
time-span before its appearance. The conventional sensitization phase cannot 
occur in just one week which indicates that it is the innate immune system 
which is the driving force behind these inflammatory reactions. 
Transcriptomic profiling also pointed towards an innate mediated reaction. 
The airway inflammation witnessed in this study seems to be somewhere 
between classical asthma and IrIA. Even though the inflammation lacked a 
sensitization phase and, in terms of its fast response, appeared to be innate 
related, it still involved Th2 cytokines, mucus production and eosinophil ia. 
Rather than allergens, the rCNT seem to act more like irritants in inducing a 
rapid and dramatic airway inflammation similar to that seen in allergic asthma. 
Recently a new non-allergic eosinophilic airway inflammation has been 
suggested, which describes a way of generating type 2 cytokines and 
eosinophils without the intervention of the adaptive immune system. This 
inflammation involves especially ILC2 (innate lymphoid cell, formerly 
“nuocytes” or “natural helper cells”) that are stimulated by the expression of 
IL-25, IL-33 and thymic stromal lymphopoietin (TSLP) from activated 
epithelial cells in the presence of irritants and environmental pollutants 
(Lambrecht et al. 2015). This type of mechanism would also seem a plausib le 
explanation for the fast Th2 type inflammation observed in publication III.  
The role of ILC2 was examined by measuring markers IL-25 and ROR-α, but 
there was no evidence of up-regulation in their expression.  However many 
other markers have been identified to associate with ILC2 and it is possible 
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that it is these agents and not those assayed here which  are active in this case 
(Barlow et al. 2014). 
 
tCNT and rCNT were compared to asbestos in publication IV. In this exposure 
study done by aspiration, there were signs of acute inflammation dominated 
by pulmonary neutrophilia that converted to eosinophilia within a week. This 
was seen with all three materials, but rCNT showed the most dramatic effects. 
Throughout the study, rCNT showed more dramatic responses than 
encountered with asbestos. There are also other studies demonstrating that 
CNT can indeed be more toxic than asbestos (Boyles et al. 2015, Sanchez et 
al. 2009).  
 
After 28 days, the inflammation was still evident, with mRNA expression of 
pro-inflammatory cytokines IL-1β and TNF-α and pro-fibrotic TGF-β. The 
tissues showed signs of granuloma formation and Charcot-Leyden- like 
crystals in acidophilic macrophages. These changes indicate possible fibrosis 
at a later time point and also reveal that the materials are not being effective ly 
cleared out from the lungs. As in publication III, also in this study there was 
evidence of Th2-associated signals such as IL-13 and goblet cell hyperplas ia.  
The finding of Charcot-Leyden-like crystals in article IV is an interesting one 
that apparently has only once before been linked to CNT (Købler et al. 2015). 
In that study, the investigators detected crystalline bodies in murine alveolar 
macrophages, multinucleated cells and lung tissue at 28 days after 
intratracheal exposure to MWCNT. They concluded that these crystals 
resembled the structures seen in eosinophilic crystalline pneumonia (ECP) that 
is especially prevalent in the C57BL/6 mouse strain. According to the 
literature, the crystals are formed after the breakdown of eosinophils and are 
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strongly linked to the presence of IL-13 (Zhu et al. 1999). This suggests a 
possible route map describing the mechanism for fibrosis (figure 11) where 
initially the responding macrophages express CXCL1 which attracts 
neutrophils. Macrophages, epithelial cells and possibly even neutrophils 
(Chen et al. 2014) then secrete IL-13 that targets the eosinophils which then 
break down, depositing their granule proteins, leading to the formation of 
Charcot-Leyden-like crystals, acidophilic macrophages and ultimate ly, 
possibly to lung fibrosis. The role of IL-13 and crystal formation in fibrosis 
induced by CNT should be studied in the future. 
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Figure 11. Inflammatory effects caused by R/CNT exposure. 
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Several studies have shown that in addition to inflammation and lung damage, 
many CNT can indeed cause granulomas and interstitial fibrosis.  MWCNT 
have also been shown to be able to migrate to the pleura and diaphragm from 
the lungs (Oberdörster et al. 2015, Ryman-Rasmussen et al. 2009). Pulmonary 
fibrosis is induced due to prolonged tissue injury or chronic inflammation. 
This involves ever-increasing numbers of fibroblasts, their differentiation into 
myofibroblasts, overproduction of extracellular matrix (ECM) proteins 
resulting in scarring of the lung tissue and eventually severe respiratory 
insufficiency (Wynn 2011). The cellular and molecular mechanisms through 
which this process takes place are not yet established, but pieces of this 
intriguing puzzle are emerging. For example, macrophages have been shown 
to act through the inflammasome, ROS, IL-1β and IL-18, platelet-derived 
growth factor (PDGF) and ERK1/2 pathway or through the NF-κβ, TNF-α, 
TGF-β, Smad/ERK1/2 pathway, ultimately causing collagen production, 
differentiation, proliferation and transition in fibroblasts and ECM 
accumulation. Another route mediated through Smad is the transition of lung 
epithelial cells into fibroblasts called the epithelial-mesenchymal transition 
(EMT) (Wang et al. 2015, Vietti et al. 2016). 
 
The role of IL-1β was studied in more detail as it has been linked to CNT and 
fiber induced inflammation in several publications (Hussain et al. 2014, 
Meunier et al. 2012, Murphy et al. 2012, Palomaki et al. 2011). In both knock-
out and antagonist experiments, the lack of bioactive IL-1β was able to prevent 
acute inflammation. This would seem to indicate that the use of these 
antagonists could be a potential way to treat acute inflammation caused by 
CNT exposure. In more chronic conditions, however it appears that Th2 type 
symptoms are not prevented by the lack of IL-1β. This also suggests a role for 
IL-1β in neutrophilia, but not in the Th2 type reaction. 
 
All in all, there does appear to be some validity in comparing CNT to asbestos. 
However as with the TiO2 materials, the inflammatory potential of different 
materials varies enormously. As described in the introduction, there are many 
factors influencing the possible toxicity of CNT, some relating to the 
nanoscale and others to the fibrous shape. In the case of the materials studied 
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in these publications, it seems that at least the shape of the material is a 
potential factor as well as what kind of agglomerates they produce. The rCNT 
that proved very toxic in all these experiments, has subsequently been 
classified as possibly carcinogenic to humans (Group 2B) by the IARC 
(Grosse et al. 2014). However this is the only CNT- material classified so far 
which underlines the diversity found throughout this novel class of materials. 
Although toxic responses across different CNT studies seem qualitative ly 
similar, quantitative differences in bioactivity are more than possible 
(Oberdörster et al. 2015). There have been some efforts to control toxicity e.g. 
through functionalization (e.g. added functional groups) and at least doping of 
MWCNT with nitrogen has been shown to control inflammation (Carrero-
Sánchez et al. 2006). Similarly, carboxylation of CNT has been shown to 
reduce bio-persistence, thus also reducing toxicity (Oberdörster et al. 2015) 
This toning down of toxicity will be an important field of study in the future. 
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5.3 Challenges in assessing toxicity of ENM 
As already stated in the introduction of this thesis, the choice of material has 
a major impact on the results as even minor changes in a material can 
dramatically alter its effects in the body. Some guidelines can be drawn, e.g. 
it is recommended to examine materials that are widely used, but ultima te ly 
the choice is often dictated by chance – research partners, availability etc. A 
good example of chance was the material referred to as cnTiO2 in the first two 
publications. This material was purchased as a pure rutile TiO2 from the 
vendor and only later was found to have been coated with SiO2. This naturally 
gave the interpretation of results a whole new aspect and also underlined the 
importance of conducting a thorough characterization of the materials being 
investigated. It is still however difficult to draw lines to what is relevant and 
sufficient in terms of characterization and there is a wide range of practices in 
the different laboratories (Bussy et al. 2012). 
 
As this thesis was focused on obtaining relevant answers especially to 
problems existing in the occupational world, the time points, doses and routes 
of exposure were chosen with occupational settings in mind. As inhalation has 
been proven as the most relevant route of exposure to nanoparticles in the 
workplace (Krug et al. 2011, Oberdörster et al. 2015), inhalation was a natural 
choice as an exposure method. Inhalation exposures, however valid and 
important, are laborious and have many restrictions, not to mention safety 
issues. This did limit the amount of exposure groups and there had to be 
emphasis placed on proper experimental design. The protocol was based on 
the best available knowledge at that point in time and limited knowledge 
sometimes complicates experimental design. Unfortunately, there is still 
limited amounts of information about the concentrations found on workplaces  
due to the novelty of ENM and partly due to the challenge of measuring the 
amounts of airborne nanomaterials. Since TiO2 has been on the market for a 
longer time, there were already some studies to give direction at the beginning 
of this thesis (Boffetta et al. 2004). Some recommended exposure levels were 
also already available for fine TiO2 particles. The American Conference of 
Governmental Industrial Hygienists (ACGIH) had assigned TiO2 fine particles 
a threshold limit value (TLV) of 10mg/m3 and the Occupational Safety & 
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Health Administration (OSHA) had set a permissible exposure limit (PEL) of 
15mg/m3 (Shi et al. 2013). However publications on measurements from CNT 
workplaces only started emerging by the time that most of the CNT inhala t ion 
exposures had been completed (Dahm et al. 2012, Erdely et al. 2013).  
 
In all inhalation experiments, the amount of airborne material was on average 
10 mg/m3. This still seems relevant in occupational TiO2 settings. Although 
according to the few studies already mentioned, these CNT doses might seem 
somewhat excessive, it is possible to justify their adoption.  During CNT 
synthesis, concentrations are most probably in the order of micrograms/m3 or 
less, but it is likely that exposure concentrations to large CNT granulates may 
be high (e.g. milligrams/m3) during the post-processing of CNT powders. 
When interpreting results from high dose studies, researchers sometimes refer 
to a phenomenon called lung particle overload described by Morrow already 
in 1988, which can lead to impairment of the alveolar macrophage clearance 
function. Originally volumetric loading of AM was used to define particle 
overload and this can still be applied for larger particles, but the particle 
surface area dose-metric has been proposed as an alternative parameter, 
especially for ENM (Borm et al. 2015). The different technical processes used 
to formulate CNT have also been proven to exert dramatic effects on their 
pulmonary fate and subsequent toxicity (Pauluhn et al. 2014).  The durations 
of daily exposures were chosen based more on technical aspects, e.g. 
restrictions on machinery, ethical considerations and time required for 
processing of samples on sacrifice days. Even if the exposure times used in 
these studies (2 and 4h) are shorter than a normal working day of 8 hours, it is 
most unlikely that workers would be exposed continuously for such long 
periods on a daily basis. 
 
Although it is possible to determine the concentrations of airborne particles, it 
is much more difficult to measure the exact doses received by individua l 
animals.  In the TiO2 studies, a relatively straightforward method existed for 
measuring the doses of individual mice. With inductively coupled plasma-
mass spectrometry (ICP-MS), it was possible to observe that TiO2 
accumulated in the lungs in a clear dose-dependent manner, with ~60% 
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clearance rate and with no significant differences between different TiO2 
materials. Lung deposition analysis was also estimated mathematically in the 
article of Koivisto et al. (2011). On the other hand, the evaluation of the actual 
CNT exposure doses of individual animals after CNT inhalation has proved 
very challenging for all researchers in the field (Pauluhn et al. 2014). As 
carbon is naturally abundant in the human body, it is hard to distinguish the 
CNTs from tissues and as such, it was necessary to utilize stained tissue 
samples to prove that the material had actually reached its target tissues. 
Mathematical and other estimations are possible (Koivisto et al. 2011, 
Koivisto et al. 2012), e.g. based on the size distribution and airborne 
concentration, it can be assumed that exposure dose of tangled-CNT is likely 
higher when compared to rigid-CNT. (Pauluhn et al. 2014) have since 
successfully used an elemental/organic total carbon method to analytica l ly 
determine the lung burden from digested lungs. However, before it will be 
possible to make a valid comparison of results from different studies, it would 
be necessary to determine lung burdens rather than simply measuring exposure 
concentrations. 
 
Estimating dosage after pharyngeal aspiration exposure poses other problems. 
With aspiration, it is possible to deliver a relatively constant dose to all 
exposed animals, but estimating how it corresponds to inhalation doses can be 
more complicated.  According to some studies (Porter et al. 2010, Shvedova 
2005) an aspirated dose of 20 μg should be equivalent to 20 days of inhala t ion 
exposure for 8 hours a day by humans at a concentration of 5 mg/m3 or an 
aspirated dose of 10 μg should be equivalent to a deposited dose in the alveolar 
region of a worker performing light work for 30 days at 400 μg/m3 (Han et al. 
2008). The doses used here were 10 and 40 μg per mouse, which according to 
available research, would seem relatively relevant from the occupationa l 
viewpoint. Naturally there is a large difference in the dose rate between 
inhalation and aspiration, as inhalation exposure happens gradually over a 
long period of time and aspiration is a single instantaneous bolus. The dose 
rate likely especially affects acute effects and high single doses can induce 
responses through mechanisms of homeostasis or particle overload that would 
not be relevant with low doses (Slikker Jr et al. 2004).  More research is 
needed to clarify the differences between these two methods, but it does seem 
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that aspiration can be used for qualitative but not quantitative risk assessment . 
Recent experiments in our lab done by repeated aspirations seem to provide 
data that is more comparable to inhalations than single doses delivered by 
aspiration (Kinaret et al. submitted), however repeated exposure requires 
repeated anesthesia, which can increase stress in the animals and this could 
obviously alter the outcome of the experiment. Another problem with 
aspiration is the fact that the particles must be suspended in a vehicle medium 
in order to be delivered to the lungs. Most nanoparticles agglomerate when 
placed in a medium, making pretreatment with dispersants necessary. This 
alters the surface properties of the particles and thus impacts on their 
biokinetics and how cells perceive the nanoparticles. Exposure through 
aspiration also usually results in a more uneven distribution of the material 
(Oberdörster et al. 2015). In publication IV we used PBS containing 0.6 mg/ml 
bovine serum albumin to disperse the material. This has been proven to be a 
good way of preventing excess agglomeration (Bihari et al. 2008). 
 
Finally, it is necessary to briefly consider the mouse strains used in this thesis. 
As in the material selection, chance can somewhat dictate the strains being 
used. As our lab had been deeply focused on allergy research long before the 
start of nano-research, the balb/c-strain, which is considered a Th2-type strain, 
had been the most widely used, most familiar and therefore the natural strain 
to adopt. The c57bl6-strain is also used in asthma research, but it was chosen 
here because these experiments were collaborations with genotoxicologis ts 
and this was a strain with which they were more familiar.  Comparing results 
even from these two rather similar and basic mouse strains is difficult and only 
broad lines can be drawn with confidence. For example, it was possible to 
discern Th2-type players activated throughout the studies as a result of ENM 
exposure, regardless of mouse strain, but whereas c57bl6 responded strongly 
with eosinophilia, balb/c mice mainly exhibited neutrophilia. It is known that 
the c57bl6 mice are more skewed to eosinophilia, which possibly explains this 
difference, but as (Watanabe et al. 2004) and (Gueders et al. 2009) both point 
out, there are multiple differences between these mouse strains. It is important 
to note, however, that as described earlier in the introduction, asthma is a 
heterogeneous disease and some patients exhibit neutrophil-predominant 
asthma sub-phenotypes (Bogaert et al. 2011). In addition, a few more specific 
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strains were used, IL-1R KO and mast cell KO mice, that were both bred from 
the same background as the WT mouse; these were used to investigate very 
specific questions. The results obtained from these mice strains were therefore 
much more straightforward to interpret.  
 
As a summary, it is important to keep in mind the different factors affecting 
the results. The inhalation and aspiration doses used in this thesis compare 
quite well and are relevant also in occupational settings. Instruments and 
techniques used to evaluate occupational exposure are developing rapidly and 
soon we will likely have more and better tools available. If aspiration proves 
a reliable substitute to inhalation in assessing pulmonary toxicity, it will make 
testing materials in vivo easier. The results seen are true for each experiment 
and mouse strain. Putting them in perspective between strains and eventually 
relative to humans is not an easy endeavor.  
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6 CONCLUSIONS AND FUTURE PERSPECTIVES 
In light of growing use of engineered nanomaterials (ENM) in a wide variety 
of applications, it has become evident that research on their safety must also 
be conducted. This thesis aimed at uncovering the possible toxicity of two 
commonly used nanomaterials, titanium dioxide (TiO2) and carbon nanotubes 
(CNT), especially in the occupational context. This work focused on the direct 
effects of repeated nanoparticle exposure on the development of lung 
inflammation in vivo. Whether exposure to nanoparticles modulates 
development of allergic asthma was also investigated. 
   
When looking at the direct effects following TiO2 or CNT exposure, it can be 
concluded that they reside on the opposite sides of the spectrum. In general 
TiO2 nanoparticles do not pose alarming risks to pulmonary health. In this 
thesis they only caused mild or moderate inflammatory effects, which were 
characterized by activated macrophages and following neutrophilia. Out of the 
two different CNT studied in this thesis, one was rather harmless (tCNT) and 
another with potentially very toxic effects (rCNT). The granulomas, AHR, 
eosinophilia, mucus producing cells, Charcot-Leyden-like crystals and 
inflammatory mediators seen in four weeks after a single aspiration exposure 
exceeded the effects seen with crocidolite asbestos. Inhalation exposure to 
rCNT revealed a novel allergic- like inflammation mediated by the innate 
immunity. It seems that rigid fibre-like CNT pose a special threat to pulmonary 
health and may eventually cause serious fibrosis and impairment of the lungs.  
 
When asthmatic mice were exposed to TiO2, the discoveries were rather 
surprising. It seemed that exposure to certain nanosized and fine TiO2 caused 
modulation in the allergic inflammation, resulting in local and systemic 
reduction of several features of experimental asthma. In contrast with e.g. 
severe effects of particulate air pollution (Gavett et al. 2001, Pandya et al. 
2002) on allergic asthma, a similar suppressive phenomenon has been seen 
with e.g. oak dust (Määttä et al. 2007) and microbe exposure (Whitehead et 
al. 2014). It would be interesting to pursue this lead and to find out more about 
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the mechanisms behind this suppression. The results could open new doors in 
understanding mechanisms of human allergic asthma. 
 
Considering human exposure to nanosized TiO2 in general, it could be 
concluded that exposure to large enough quantities of TiO2 to cause serious 
harm is somewhat unlikely. However considering the very wide use of TiO2 it 
is crucial to design products and manufacturing processes in ways that do not 
allow TiO2 to accumulate in humans or the environment. In the case of CNT, 
significant release and following exposure from consumer products is  
unlikely, if one excludes manufacturing and processing, tires, recycling and 
their potential use in textiles. Even in the above mentioned scenarios, the 
exposure levels will be low (Guseva Canu et al. 2016). Special attention 
should still be paid to new MWCNT that are designed, produced and used in 
application. Without thorough toxicity evaluation (e.g. LOAEL, follow-up 
studies) they should always be treated as potentially hazardous materials. 
 
As both studied materials, TiO2 and MWCNT, are already being introduced 
into novel areas e.g. in diagnostics, pharmacology and therapeutics, it is good 
to also keep in mind the numerous advantages of these materials. For example, 
TiO2 has demonstrated potential as a cancer drug due to its photocatalyt ic 
killing effect  (Sha et al. 2013). CNT on the other hand, can be used to deliver 
drugs to specific sites in the organism due to the fact that they are hollow and 
with functionalization easily targeted to specific sites (Amenta et al. 2015). 
This exciting development should still always proceed hand-in-hand with 
toxicological testing. 
 
Due to the rapidly growing numbers of different ENM, vivid toxicity testing 
cannot be performed on all new materials. Standard in vitro tests to assess 
basic ENM toxicity will hopefully become available in the near future and 
they will most likely be enough for pre-evaluated low risk ENM. For example 
thorough characterisation can give vital clues about the possible toxicity of 
ENM. The situation at the moment calls for actual exposure studies to be 
conducted to provide solid evidence of possible exposure scenarios. However, 
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the analytical methods available have great problems monitoring exposure in 
real-world conditions (Guseva Canu et al. 2016, Liou et al. 2015).  
 
The main contributions of this thesis could be summarized as providing 
information on a potential inhibitory mechanism of allergic asthma, helping to 
unveil mechanisms of a new Th2 type eosinophilic airway inflammation and 
providing new information on diverse abilities of different ENM to impact the 
immune system. This information can be further utilized in hazard assessment.  
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